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Abstract 
Objectives: A multifactorial approach is recommended for the identification/diagnosis, 
prognosis, and treatment of pain in knee osteoarthritis (OA). One aspect of this approach 
includes illness perception and behaviour. The purpose of this thesis was to investigate the 
measurement of illness perception and behaviour along a continuum of symptomatic knee 
OA, starting from the early symptoms of knee OA.  
Methods: Three studies were conducted to fulfill this purpose. The first study was a scoping 
review that applied an interpretative analysis to validated measures that had been used to 
assess people with knee pain and/or knee OA. Second was the construct validation of a 
measure of illness perception and behaviour in people with early symptoms of knee OA and 
confirmed knee OA. Third was a study of a rat model of post-traumatic knee OA that was 
undertaken to identify behavioural measures that were significantly different between rats 
with and without knee OA.  
Results: The scoping review identified 16 validated measures that capture components of 
illness perception and behaviour. Only one measure, the Questionnaire to Identify Knee 
Symptoms (QuIKS), capture all four components of illness perception and behaviour. In the 
second study, a version of the QuIKS called the QuIKS-R was found to be unidimensional 
and to provide interval-level scaling of illness perception and behaviour. In the third study, 
ipsilateral weight-bearing deficit and vertical activity limitations were identified as two 
behavioural measures that differed between the rat model of post-traumatic knee OA and 
control groups. 
Conclusions: The three studies in this thesis identified measures that could be important in 
advancing the identification and care of people with symptoms of knee OA, in terms of 
clinical care, clinical research with humans and preclinical research with the rat model of 
post-traumatic knee OA.  
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Chapter 1  
1 General Introduction 
At the foundation of this thesis is the quest for a deeper understanding of the measurement 
of ‘illness perception and behaviour’ in the experience of symptomatic knee osteoarthritis 
(OA). According to Petri et al. (2007; p. 163), illness perception as a unique concept can be 
defined as “the organized cognitive representations or beliefs that patients [or people] have 
about their illness”.1 In general, behaviours are the internally coordinated responses (action 
or inaction) to internal or external stimuli, with the exclusion of developmental changes.2 In 
contrast, ‘illness perception and behaviour’ is used as a unified concept in this thesis by 
applying Mechanic’s (1986; p. 1) definition of illness behaviour, which states that “it 
[illness behaviour] refers to the manner in which individuals monitor their bodies, define 
and interpret their symptoms, take remedial action, and utilize sources of help as well as the 
more formal health care system”.3  
In this thesis, a transdisciplinary approach was used to study the assessment of illness 
perception and behaviour along a continuum of symptomatic knee OA. This means the 
dissertation is comprised of both human and animal studies. 
 
1.1 Knee OA 
The knees are among the most common sites of OA. Knee OA is usually debilitating, is 
characterized by joint deterioration at the level of the articular cartilage as part of the wider 
disruption of the biology of the whole joint, and can result in varied levels of pain in and/or 
around the knee, loss of physical functioning, activity limitations, participation restrictions, 
psychological distress, and reduced quality of life.4-6 Recently, the Osteoarthritis Research 
Society International (OARSI) proposed a standardized definition of OA that reads, 
“Osteoarthritis is a disorder involving movable joints characterized by cell stress and 
extracellular matrix degradation initiated by micro- and macro-injury that activates 
maladaptive repair responses including pro-inflammatory pathways of innate immunity. 
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The disease manifests first as a molecular derangement (abnormal joint tissue metabolism) 
followed by anatomic, and/or physiologic derangements (characterized by cartilage 
degradation, bone remodeling, osteophyte formation, joint inflammation and loss of normal 
joint function), that can culminate in illness”.7, 8  
Knee pain is a reliable indicator of symptomatic knee OA, even when OA-related structural 
changes of the joint are not present on plain radiographs.5, 6, 9, 10 While knee pain is an 
integral part of the clinical diagnosis of symptomatic knee OA in people aged 40 years and 
over,9, 11 it should be recognized that there is a discordance between the presence of knee 
pain and radiographic knee OA.12, 13 One review found that 15% to 76% of people with 
knee pain had radiographic knee OA, whereas 15% to 81% of people with radiographic 
knee OA had knee pain.12 Also, the prevalence of symptomatic knee OA is generally lower 
than its radiographic counterpart, and the definition of symptomatic knee OA affects 
estimates of its prevalence.9, 14  
The prevalence of symptomatic knee OA varies around the world. The crude prevalence 
estimates fall between 5.4% and 24.2% in adult populations, and prevalence rates are 
highest in older age groups.14 In general, over 10% but fewer than 25% of people aged 50 
years or more  have been reported to have symptomatic knee OA.14 For example, in the 
United States of America (US), symptomatic knee OA is reported to affect about 10% of 
men and 13% of women aged 60 years or more.5 Another US study showed that the 
prevalence of both knee pain and symptomatic knee OA has been on the rise, increasing 
twofold or more from 1983 through 2005 in a community cohort of people aged over 70 
years.15 Subsequently, data from a 2007 to 2008 nationwide survey in the US estimated a 
13.8% lifetime risk for symptomatic knee OA in people aged 25 years or more.16 
Furthermore, the estimated lifetime risk was as low as 0.7% for non-obese men aged 25 
years to 34 years and rose to 32.4% for obese women aged 85 years or more.  
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1.2 Impact and management of knee OA in Canada 
In Canada, 13% (4.4 million) of the population aged 15 years or more had OA in 2010 with 
a forecasted increase to 22.9% by 2032.17 It has been estimated that $488 billion dollars 
could potentially be saved in the direct and indirect costs of OA between 2010 and 2040 if 
adequate pain management strategies for OA are implemented.17 Knee OA has had a 
substantial financial burden on individuals and society. For example, $398 million dollars 
were spent on acute care during hospitalization for unilateral knee replacements in 2012-
2013, making it by far the most costly intervention in Canada for that year.18 Accordingly, 
in the year 2013 to 2014, knee OA was the fifth highest reason for hospitalization, in terms 
of volume and average length of stay, in Canada.19  
No cure currently exists for knee OA.20 However, important strategies for combatting 
symptomatic knee OA include early recognition and application of self-management 
techniques, and clinical intervention strategies such as exercise, patient education and 
weight-loss.21-29 In line with established clinical guidelines, knee OA is typically treated 
with various types of conservative treatments, pharmacotherapies, and surgical modalities 
that are focused on relieving knee pain and discomfort, augmenting functional capacity, 
maintaining and improving physical activity levels, and thus on improving quality of life.21-
29
  
When less invasive and aggressive therapies fail to resolve the ill-effects of knee OA, total 
knee replacement (TKR) has become the standard approach for treating end-stage knee 
OA.21-30 Between 2013 and 2014, a total of 59,388 knee replacement surgeries were 
performed in Canada, which constituted the second most frequently performed surgical 
intervention in the country, second only to caesarean section.19 In that same year, 97.1% of 
all TKRs were for treating knee OA.31 Additionally, compared  to five years earlier, 8.5% 
more total joint replacements were performed, which constituted a 14.8% to 16.0% increase 
in TKRs among people aged 45 to 64 years, whilst TKR remained most prevalent among 
those between 65 and 84 years of age.31 Yet one Canadian study found that 14% to 28% of 
people who received primary TKR in Ontario were not satisfied with pain relief and 16% to 
30% were not satisfied with their level of function.32 Also, one study found a little over 1% 
to about 7% of artificial knee joints did not survive beyond 10 years.33 This raises concerns, 
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especially given the increase in younger people having the procedure,  and the current trend 
in greater life expectancy and population age in Canada.31, 34 The preceding facts reflect the 
need to implement strategies to detect and manage symptomatic knee OA earlier in primary 
care practice and in community settings in order to delay or prevent the need for knee 
replacement surgeries.  
 
1.3 Assessment of symptomatic knee OA 
It is imperative that symptomatic knee OA is recognized during its early stages, if 
appropriate primary care interventions are to be effectively utilized. Kittelson et al. (2014) 
shared their perspective that the future of diagnosis, prognosis and treatment of 
symptomatic knee OA rests on leveraging the equitable contribution of knee joint 
pathology, pain neurophysiology, and psychological distress to the phenotypes of pain in 
knee OA.35 Imaging technologies are the standard measures for diagnosing knee OA.6, 36 
While imaging technologies focus on structural changes at the joint, pain and disability are 
among the main reasons people with knee OA seek care.37 The measurement of knee pain 
and physical, psychological, and social functioning factors related to knee OA are usually 
subjective and require self-reporting by the affected individual.38-40 Psychological distress 
(cognitive, psychosocial, and behavioural factors) plays an integral role in the 
recognition/diagnosis and treatment of symptomatic knee OA, and is consistent with what 
individuals report about their lived experiences with knee pain/OA.41-44  
 
1.4 Lived experience with symptomatic knee OA 
During the last decade, several qualitative studies have made important contributions to our 
understanding of the lived experiences of people with knee pain/OA.41-44 A systematic 
review of qualitative studies on people with OA, with a majority having knee OA, showed 
that people’s attitudes were influenced by how severe their OA symptoms were, whether 
their level of function was affected, how much they knew about the disease, and how they 
perceived others viewed their condition.42 Among these people, an overarching theme was 
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that their decision to seek professional diagnosis was delayed while they self-managed their 
condition and gathered information through informal rather than formal sources.42 
Diagnosis was not sought until people reached a critical point. Even then, self-management 
continued until there was an ‘inevitable’ need for knee joint replacement.43 A qualitative 
meta-synthesis found that the decision to undergo TKR was shaped by one’s experience 
with pain, the perceived role of health professionals, thoughts on the treatment options and 
outcomes, the perceived cause of the condition, and social context.41 Subsequently, post-
surgery recovery outcomes, both short and long term, were thought to be determined by 
one’s life context and coping strategies.41  
In the context of people living in Canada with mild-to-moderate symptomatic knee OA or 
knee OA-like pain, their attitudes, behaviours, beliefs, intentions, and perceptions are 
related to how their knee symptoms shape their lived experience.45-49 These contextual 
factors have been implicated in the negative effects of the early symptoms of knee OA, 
effect such as decreased engagement in meaningful physical activity and social roles, and 
deteriorated emotional wellbeing.45-49  Furthermore, contextual factors were implicated in 
the evaluation of one’s own health, the search for information, the implementation of self-
management strategies, the seeking of lay-person and professional care provider support 
through interpersonal interactions and for conservative treatment, and finally the seemingly 
inevitable decision for surgery.45-49   
 
1.5 Measures of illness perception and behaviour 
Illness perception and behaviour has been operationalized in many measures that have been 
used to assess attitudes, behaviours, beliefs, coping strategies, and perceptions related to 
illness in people with various medical conditions.1, 50, 51 Consistent across the studies of its 
conceptualization and operationalization, is the message of the importance of illness 
perception and behaviour in the recognition and management of medical conditions, and  
the demonstration of it having significant associations with physical and psychological 
adjustments to medical conditions.3, 50-52 The measurement of illness perception and 
behaviour as it relates to knee symptoms could be critical for the implementation of 
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professional-guided conservative management strategies in early symptomatic knee OA.49, 
53
 For example, one study successfully used ‘illness behaviour’ as the first filter in a model 
that identified people with hip or knee pain problems within the community who have OA 
and utilized health care.54, 55 Self-report questionnaires such as the Arthritis Self-Efficacy 
Scale (ASES) have measured the beliefs of people with symptomatic knee OA regarding 
their ability to manage their pain, the presence of other symptoms, and the performance of 
certain physical functions.56, 57  These beliefs have been important outcomes associated with 
pain and the level of physical function of people with symptomatic knee OA who 
participated in various arthritis self-management programs.56, 57 
Some questions about the development, progression and treatment of knee OA are too 
challenging to be conducted using humans due to the cost and time required to monitor 
people over many years. Using an animal model provides experimental control over the 
induction of OA with varying degrees of severity and also provides more certainty around 
the establishment of mild-to-moderate OA structural changes in relatively short timelines. 
Furthermore, animal samples can be controlled to have high levels of biological 
homogeneity. These characteristics make animal models attractive for studying the 
measurement of the joint pathological and the pain neurophysiological aspects of OA, as 
well as the measurement of the psychological-related components of OA such as changes in 
behaviour. 
 
1.6 Rodent models in knee OA research 
Rodent models are commonly used as surrogates for the study of knee OA in humans.58  
They allow for the experimental study of knee OA in ways that would normally be 
considered unethical, even impossible in human beings, such as the induction of disease and 
sacrifice after a therapeutic intervention.59 There are several rodent models of knee OA that 
are based mostly on methods of chemical induction (e.g. mono-sodium iodoacetate) or 
surgical induction (e.g. anterior cruciate ligament transection).58 The surgically-induced 
rodent models are particularly relevant to the study of post-traumatic knee OA.58  
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In humans, an anterior cruciate ligament (ACL) tear increases the risk of symptomatic knee 
OA, with up to 80% of people developing radiographic knee OA and up to 46% developing 
symptomatic knee OA within 10 to 15 years.60-62  People with ACL reconstruction and 
meniscectomy are more likely to have knee OA than people with ACL reconstruction and a 
normal meniscus.60, 63 Furthermore, there is no convincing evidence that surgical 
interventions for knee joint injury protect against future knee OA.64 Rat models of knee OA 
that were created through destabilizing the knee joint using ACL transection and 
meniscectomy have been reported to demonstrate structural joint changes characteristic of 
knee OA within as little as two weeks after the operation.65 Thus, the knee OA pathology 
and its response to therapy can be studied in a relatively short period of time and without 
injury to humans. 
While pain and disability in humans with knee OA are typically assessed using self-reports 
and performance-based measures, the histology of joint changes and reflexes evoked by 
sensory stimuli are usually the primary outcome measures in preclinical rodent models of 
knee OA.39, 66-68 This difference in measuring the effectiveness of therapies challenges the 
translation of preclinical research to clinical settings, because important components of the 
phenotype of the condition are not accounted for when evaluating the outcomes of 
preclinical rodent research.67, 69 Behavioural measures of pain in rodent models of knee OA 
provide a closer and more realistic measure of clinical pain.58, 69-72  Therefore, including 
assessments of behavioural changes, such as changes in physical activity, in preclinical 
rodent models of knee OA could provide information comparable to self-report or 
observational methods of illness response in humans.67, 69 To fill this gap, the assessment of 
behavioural alterations such as changes in physical activities, possibly brought on by 
movement-induced pain, are becoming more of an integral part of assessing the outcomes 
of experiments using rodent models of knee OA.58, 69-73 These behavioural outcomes include 
measures such as changes in gait, weight-bearing symmetry, and locomotor activity.58, 69-73 
The inclusion of these measures better account for the complexity that forms the experience 
of having knee OA. Furthermore, the inclusion of behavioural measures as outcomes in 
research using rodent models of knee OA is thought to increase the validity of the models.69  
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1.7 Overarching Objective  
Illness perception and behaviour is an important aspect of the lived experience of people 
with symptomatic knee OA. If properly measured, illness perception and behaviour could 
help in providing more well-rounded descriptions of an individual with knee pain/OA 
condition for informing the individual’s therapy. Therefore, the overarching objective of 
this thesis was to identify measures of illness perception and behaviour used with people 
that are on a continuum of symptomatic knee OA with a greater emphasis on emergent and 
early stages of symptomatic knee OA. Also, my transdisciplinary approach sought to 
identify measures of behaviour in a preclinical rat model of knee OA with joint pathology 
characteristic of mild-to-moderate knee OA.    
 
1.8 Research plan 
A systematic synthesis of the research literature that documents validated measures of 
illness perception and behaviour in people with knee pain/OA does not exist. Undertaking 
such a study was considered to be a valuable first step in assessing the need for a measure 
that captures the illness perception and behaviour of people with emergent or early 
symptomatic knee OA. It is expected that a measure of illness perception and behaviour 
could be integral in the recognition of people as members of this population during primary 
care consultation or in the community and later in the selection of appropriate treatment 
protocols.74 Beyond synthesizing the research literature on these measures, an interpretive 
approach was planned as a part of the methodology of the review. This was planned in order 
to understand how comprehensively the measures assess illness perception and behaviour.  
As a natural extension to the findings of the systematic synthesis, a psychometric evaluation 
was planned for the Questionnaire to Identify Knee Symptoms (QuIKS) to strengthen its 
value as an assessment measure of illness perception and behaviour for use to identify 
people who are experiencing some symptoms consistent with knee OA. This second study 
was needed to raise its scaling to an interval-level as recommended as a part of the 
development and validation of measurement methods.75 In this second study, plans were 
 9 
 
made to provide preliminary interpretation of the QuIKS’s interval-level scale using a 
known-group analysis of people along a continuum of symptomatic knee OA.  
The third and final study was planned as a contribution to the development of a more robust 
rat model of knee OA that integrates behavioural alteration due to knee OA as a component 
of the model. The plan was to investigate certain behaviours that are an integral part of the 
human experience of knee OA for their possible use as outcome measures that could be 
routinely included in studies using a preclinical rat model of post-traumatic knee OA.    
The three studies are presented in the next three chapters. Chapter two is a scoping review 
of validated measures that were interpreted as assessors of illness perception and behaviour 
in people with knee pain/OA. Chapter three is a version of the QuIKS that provides 
interval-level scaling for the measurement of illness perception and behaviour for people 
along a continuum of symptomatic knee OA. Chapter four provides behavioural measures 
that can form a part of routine outcome measurement in a surgically-induced rat model of 
post-traumatic knee OA. The final chapter of the thesis provides a discussion of the totality 
of the research conducted including implications for management for people with knee OA 
and future research directions. 
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Chapter 2  
2 Validated measures of illness perception and behaviour 
A version of this chapter is presently under review for publication in a peer-reviewed 
journal. 
2.1 Abstract 
Objective: To identify validated measures that capture illness perception and behavior and 
have been used to assess people who have knee pain/osteoarthritis (OA).   
Methods: A scoping review was performed. Nine electronic databases were searched for 
records from inception through April 19, 2015. Search terms included illness perception and 
behavior, knee, pain, osteoarthritis, and their related terms. This review included English 
language publications of primary data on people with knee pain/OA assessed with validated 
measures capturing any of four components of illness perception and behavior: monitor 
body, define and interpret symptoms, take remedial action, and utilize sources of help. 
Initially, one reviewer screened the titles and abstracts of 11,151 publications. Then, two 
reviewers independently screened the full-text of 153 publications. Subsequently, 71 
publications were analyzed. Two reviewers independently charted and coded the measures 
into the four components.  
Results: Sixteen measures were identified that capture components of illness perception 
and behavior in the target population. Coding results indicated that 31, 69, 75 and 31 
percent of these measures included the monitor body, define and interpret symptoms, take 
remedial action, and utilize sources of help components, respectively.  
Conclusions: Several validated measures were interpreted as capturing some components, 
and only one measure was interpreted as capturing all of the components of illness 
perception and behavior in the target population. A measure that comprehensively captures 
illness perception and behavior could be valuable for informing and evaluating therapy for 
patients along a continuum of symptomatic knee OA. 
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2.2 Introduction 
Thirteen percent of Canadians had OA in 2010, with a projected increase to 22.9% by 
2032.1 In the United States (US), the estimated lifetime risk of developing symptomatic 
knee OA is 13.8% for adults aged 25 years and more.2 People with knee pain and knee OA 
represent a large and growing global population of people with disability.3,4 Accordingly, 
knee OA is the leading cause of chronic disability among community-dwelling older adults, 
primarily due to knee pain.5, 6 Furthermore, people with symptomatic knee OA may have 
substantial inter-individual variation in their illness response, such as seeking care and 
taking medication.7,8 
A number of theories and models from the behavioural and social sciences identify concepts 
that are relevant to the ways that individuals with health conditions appraise, evaluate, 
perceive and respond to illness.9-16 They include theories related broadly to stress, coping 
and adaptation; theories that discuss individual differences or personality and its 
relationship to illness responses, as well as biopsychosocial frameworks or theories that are 
specific to managing diseases, illnesses or other health problems.9-16  For example, 
Mechanic (1986: p.1) defined illness behaviour as “the manner in which persons monitor 
their bodies, define and interpret their symptoms, take remedial action, and utilize various 
sources of help including the formal health-care system”.17 Research on illness perception 
and behaviour is scattered and segmented in the medical literature, covering concepts such 
as appraisals, perceptions, coping strategies, care-seeking behaviour, sick roles, and 
personal difference factors.18-20 The broad concepts surrounding illness responses fit with 
the contemporary biopsychosocial framework, which views illness as a complex 
relationship between biomedical and psychosocial factors.16,20,21  
Three main models of illness contributed to our understanding of illness perception and 
behaviour as it applies to knee pain/OA. First is the model of illness behaviour.14 This 
model describes different phases in order to explain an individual’s decision-making when 
seeking relief during illness. These include the recognition, appraisal and labeling of an 
illness; evaluating the meaning and significance of the illness; responses to health problems 
such as seeking out and assessing treatment options and weighing the benefits and costs of 
treatment; and illness management responses or behaviours like selecting and adhering to a 
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treatment plan. Finally, any new information or health changes are re-evaluated, making the 
model cyclical as an individual may return to some of the previous phases.14   
Second is the common-sense model of illness representation (or Leventhal’s self-regulatory 
model of illness behaviour).16,22 It has several parallels with the model of illness behaviour. 
For example, both models describe the role of illness history and the somatic self in 
determining how information about an illness is processed.14,16 The common-sense model 
pays specific attention to the role that internal and external influences play in cognitive and 
emotional responses to stimuli, in appraisal, and in coping, with particular focus on 
personality variables or individual difference factors, as well as cultural and interpersonal 
contexts.16  In the common-sense model, cognitive level processes or health threats revolve 
around five attributes of illness representation: the identity of the illness, the timeline that 
describes the duration and pattern of symptoms, the attributable causes that elicit 
symptoms, the perceived controllability of the stimuli, and the imagined consequences of 
the illness.16  
Third is the model of selective optimization with compensation, which describes a general 
process of adaptation that can be applied to any illness.15,23 The model has previously been 
described for the adaptation of older adults with OA to disability.23 It has three components: 
selection, the giving up or restriction of activities because of reduced functional capacity; 
optimization, the individual’s augmentation of their capacity to engage in desired tasks; and 
compensation, the changing of strategies used to continue engaging in specific tasks despite 
the loss of capacity.23  
Previous reviews have looked at the conceptualization and operationalization of illness 
perceptions, appraisals and behaviours.18-20,24 These reviews have also highlighted their 
importance in the assessment and management of health conditions by clinicians.18-20 Prior 
and Bond (2013) noted that the primary purpose of the operationalization of illness 
behaviour is for individual-level assessment of the illness response, and posited the idea that 
illness behaviour has both covert (affective and cognitive) and overt (observable) 
aspects.20,25 Consistent with this, Sirri et al (2013) argued that illness behaviour unifies 
diverse  concepts  in the medical literature that may improve illness recognition and a 
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patient’s medical care.18 Moreover, these concepts not only may help clinicians better 
understand decision making, coping, self-management, and treatment adherence; but they 
may also be useful as outcome measures of change in perceptions or behaviours after 
treatment.  
In the present study, measures were sought that capture illness perception and behaviour 
and which could be used during the rehabilitation of people with knee symptoms consistent 
with symptomatic knee OA. Therefore, the aim of this study was to identify validated 
measures that capture illness perception and behaviour and were used to assess people who 
have knee pain/OA. 
 
2.3 Methods 
2.3.1 Study design  
The published research literature was reviewed using the systematic methodological 
framework for scoping studies developed by Arksey and O’Malley (2005).26 This study also 
incorporated some of the recommendations for its enhancement when used in health 
research.27,28 Following this framework, we: 1) identified the research question, 2) 
identified relevant publications, 3) selected the qualifying publications, 4) charted the data, 
5) collated, summarized, and reported the results, and 6) consulted with stakeholders, which 
included two experts in psychosocial theory, chronic diseases such as OA, rehabilitation, 
and measurement. 
 
2.3.1.1 Stage 1: Identification of the research question 
First we formulated the following research question: What are the available validated 
measures of illness perception and behaviour used with people who have knee pain and 
knee OA? Illness perception and behaviour as a unified concept followed Mechanic’s 
(1986) definition of illness behaviour.17 This definition is applicable to clinical management 
of pain/OA because it encompasses both covert and overt responses to illness.20 
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2.3.1.2 Stage 2: Identification of relevant publications 
Search strategy. The search strategy was informed by a health sciences librarian. Search 
was done of all the online records up to October 20, 2014 of nine electronic databases and 
grey literature, namely: AMED, CINAHL, Cochrane Library, EMBASE, Health and 
Psychosocial Instruments, Open Grey, ProQuest Research Library (all 65 databases), 
PubMed, and Web of Knowledge. Using Boolean logic, the search terms included: illness 
behaviour, knee, pain, and osteoarthritis, each with related terms. Box 2.1 provides a full 
list of the search terms. One co-author (C.B.H. and M-K.W.) screened the reference list of 
the publications included in the final selection. Also, the names of the eligible validated 
measures were used to search for additional relevant publications.  
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Box 2.1. Search strategy for identifying studies before consultation 
• Databases (inception to October 14, 2014) 
AMED, CINAHL, Cochrane Library, EMBASE, Health and Psychosocial 
Instruments, Open Grey, ProQuest Research Library (all 65 databases), PubMed, 
and Web of Knowledge 
• Search terms 
[Illness perception and behaviour related terms: “sick role” OR “illness 
behaviour/behavior” OR “help seeking behaviour/behavior” OR “health seeking 
behaviour/behavior” OR “information seeking behaviour/behavior” OR “care 
seeking behaviour/behavior” OR “health care seeking behaviour/behaviour” OR 
“healthcare seeking behaviour/behavior” OR “self-care” OR “pain 
behaviour/behavior” OR “self-management” OR “treatment seeking 
behaviour/behavior” OR “adaptive behaviour/behavior” OR “health care 
utilization” OR “information seeking” OR “coping behaviour/behavior” OR 
“coping behavior” OR “illness response” OR “severity of illness index” OR 
“severity of illness indices” OR “illness experience” OR “treatment adherence” 
OR “symptoms response” OR “pain response” OR “self-regulation” OR 
“professional regulation” OR “professional care” OR “self-monitoring”] AND 
[Knee related terms: “knee” OR “knee joint” OR “patellofemoral joint” OR 
“tibiofemoral”] AND [The condition related terms: “pain” OR “osteoarthritis” 
OR “knee osteoarthritis” OR “osteoarthritis, knee”] 
• Journals  
None searched 
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2.3.1.3 Stage 3: Study selection 
Inclusion criteria. We defined the four components of illness perception and behaviour 
identified within Mechanic’s (1986) definition,17 (see Box 2.2.): (i) Monitor body means 
maintaining focus on the occurrence of symptoms and factors contributing to symptom 
episodes.29 (ii) Define and interpret symptoms refers to an individual’s attempt to decipher 
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meaning and place significance on their symptoms including their perceived ability to 
manage them.29 (iii) Take remedial action means applying lay- or professionally-guided 
care to control one’s symptoms or progression of the disease, such as the avoidance of knee 
pain triggering activities, the use of pain medication, or self-talk.30,31 (iv) Utilize sources of 
help means help through interpersonal interaction with either lay or professional care 
providers regarding one’s illness or symptoms.31,32 We included quantitative studies that 
reported primary data from people with knee pain/OA, who were assessed with a measure 
that was previously validated or validated as part of the study. Measures were considered 
validated if, at the minimum, they had evidence of content validation in any population. 
Also, each measure had to be available in English and provide an individual-level scoring 
method. The full version of each validated measure or its validated subsections (e.g. 
subscales or factors) were eligible. Furthermore, the validated measure had to be interpreted 
as capturing one or more components of illness perception and behaviour. 
Exclusion criteria. We excluded animal studies, qualitative studies, and publications that 
were not available in English. Publications were also excluded when subjects were 
diagnosed with rheumatoid arthritis, fibromyalgia, generalized pain, generalized OA, or 
were post-surgical. Also, exclusion during full-text screening focused on the following four 
criteria: the publication: 1) did not use a validated measure of illness perception and 
behaviour; 2) did not specify a sample with knee pain and/or knee OA; 3) contained a non-
English measure with no evidence of cross-cultural validation with an English language 
equivalent; and 4) a full-text or measure was not found. 
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Box 2.2. Definition of illness perception and behaviour components 
• Monitor body means maintaining focus on the occurrence of symptoms and 
factors contributing to symptom episodes.  
• Define and interpret symptoms refers to an individual’s attempt to decipher 
meaning and place significance on their symptoms including their perceived 
ability to manage them.  
• Take remedial action means applying lay- or professionally-guided care to 
control one’s symptoms or progression of the disease, such as the avoidance of 
knee pain triggering activities, the use of pain medication, or self-talk.  
• Utilize sources of help means help through interpersonal interaction with either 
lay or professional care providers regarding one’s illness or symptoms. 
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Screening, full-text and measure review. All of the retrieved publications were placed in a 
citation management system. A sample of 300 publications was independently screened by 
two reviewers (C.B.H. and M-K.W.). This was done to refine the inclusion and exclusion 
criteria. In a sequential and iterative process, one reviewer (C.B.H.) screened the titles and 
abstracts of all the initial set of publications retrieved by the search strategy. Some 
publications were excluded at this stage. We retrieved those publications judged to be 
possibly eligible. Then, full-text review of the remaining publications was independently 
performed by two reviewers (C.B.H. and M-K.W.). When the reviewers disagreed on 
eligibility, advice was sought from a third investigator (B.M.C.), and the decision was made 
by consensus on whether to include the publication. We then retrieved the measures from 
the included publications. The final decision to include a publication consisted of analysing 
each item of the relevant validated measure by assessing how well it fit with the definition 
of each of the four components. 
 
2.3.1.4 Stage 4: Charting the data 
A data charting form was developed and used to record key information extracted from the 
final set of included publications. Two reviewers (C.B.H. and M-K.W.) independently 
recorded the following information from the included publications: 
• Author(s), year of publication, country of study 
• Aim of study 
• Population  
• Methodology 
• Name of relevant validated measure 
 
2.3.1.5 Stage 5: Collating, summarizing and reporting results 
We applied a directed approach to the qualitative content analysis of the text data for each 
measure by collating,33 summarizing, and reporting the results in a way that provided a 
narrative account of the data.28 Content analysis required analytical re-interpretation of the 
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items in the validated measures to determine whether they fit with the core concept of 
illness perception and behaviour. The four components defined above were used as key 
categories for coding the content of each measure.33  Particular attention was placed on 
identifying any gaps in the measurement of illness perception and behaviour within the 
target population. We have provided a summary of the included measures. Inter-rater 
agreement when coding the measures to each component of illness perception and 
behaviour was calculated using the kappa statistic. Statistically significant (P < 0.05) values 
of kappa from 0.21 to 0.40, 0.41 to 0.60, and 0.61 to 0.80 were interpreted as fair, moderate, 
and substantial agreement between raters, respectively.34  
 
2.3.1.6 Stage 6: Consultation exercise 
After the first draft of the manuscript, we sought two experts’ opinion to inform and 
validate our findings.28 We had two consulting researchers: a clinician researcher (A.M.D.) 
who focuses on OA, measurement, and rehabilitation – particularly related to the 
experiences of people with early-to-moderate symptoms who are looking to manage and 
prevent progression; and, a researcher (M.A.M.G.) with a health psychology background in 
chronic disease, coping and measurement. They reviewed the initial draft of this 
manuscript, provided insightful critiques and recommendations, and were involved from the 
preparation of the manuscript through to the final draft submitted for publication.27 
After the initial consultation, we performed a second search on April 19, 2015 using the 
terms listed in Box 2.3. Two key journals were hand-searched: Health Psychology and 
Journal of Behavioural Medicine. Also, given the new insights from the consultation, the 
full-text results from before the consultation were rescreened for additional publications and 
measures. 
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Box 2.3 Search Strategy for identifying studies after consultation 
• Databases (inception to April 19, 2015) 
AMED, CINAHL, Cochrane Library, EMBASE, Health and Psychosocial 
Instruments, Open Grey, ProQuest Research Library (all 65 databases), PubMed, and 
Web of Knowledge 
• Search terms 
Search Terms: [Illness perception and behaviour related terms: “informal 
support” OR “support seeking” OR “formal support” OR “illness perceptions” OR 
“pain perceptions” OR “psychosocial perceptions” OR “health perceptions” OR 
“illness appraisals” OR “illness evaluations” OR “pain appraisals” OR “illness 
evaluations” OR “pain appraisals” OR “pain evaluations” OR “illness monitoring” 
OR “pain monitoring” OR “illness support” OR “adaptation” OR “pain vigilance” 
OR “illness vigilance”] AND [Knee related terms: “knee” OR “knee joint” OR 
“patellofemoral joint” OR “tibiofemoral”] AND [The condition related terms: 
“pain” OR “knee symptoms” OR “osteoarthritis” OR “knee osteoarthritis”] NOT 
[“qualitative]. Where possible the search limits included English Language and 
Human. 
• Journals (Inception to April 24, 2015) 
• Health Psychology  
• Journal of Behavioural Medicine 
 
• Rescreened full-text results obtained before consultation 
n = 79 
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2.4 Results 
2.4.1 Data synthesis 
Figure 2.1 outlines the data selection process. The searches before the consultation 
produced 8028 publications, with 6534 publications remaining after the removal of 
duplicates. Subsequently, 6455 publications that were ineligible were excluded prior to the 
full-text review. The main reasons for excluding a publication after screening only its title 
and abstract were that the publication was: an animal study, not written in English, a 
conference abstract, a study of a post-surgical population, a study involving an excluded 
disease, not related to knee pain or knee OA, a publication without a measure of the 
concept, a qualitative study, or a review paper. The searches after consultation produced 
4995 publications, and subsequently 4617 publications without duplicates. The full-text of 
79 publications (before consultation) and 74 additional publications (after consultation), 
totaling 153 publications were screened, of which 71 publications and their relevant 
validated measures had their information charted and analysed.  
 
  
Figure 2.1 Flow chart of study inclusion and exclusion 
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2.4.2 Components of illness perception and behaviour in each 
measure 
Table 2.1 shows the 16 validated measures identified in publications between 1987 and 
2014. Eleven measures were identified before consultation and five after consultation. The 
components of these 16 measures are presented in Table 2.1. We included multiple versions 
or factor structures of some measures, for example the Coping Strategies Questionnaire 
(CSQ), see Table 2.2 that presents a summary of the measures and how they were used. For 
other measures, we included only the subscales used in the included publications, such as 
only the religious coping subscale of the Coping Orientation to Problems Experienced 
(COPE) inventory.35,36  
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Table 2.1 Sixteen validated measures that capture components of illness perception and behaviour. 
Validated measure* 
Illness Perception and Behaviour Components 
Summary of  
Population 
Number of Articles 
and Study 
Locations 
Publications 
Index 
Article 
of 
measure 
Monitor 
Body 
Define & 
Interpret 
Symptoms 
Take 
Remedial 
Action 
Utilize 
Sources 
of Help 
Arthritis Self-Efficacy Scale (ASES)† 
 
 
x 
 
  
Painful 
early/advance 
knee OA, 
hip/knee OA, 
non-acute 
hip/knee pain, 
OA-like knee 
pain 
n=29 (2=Canada, 
2=Denmark, 
2=Netherland, 
1=Taiwan, 20=US, 
1=Australia/Canada
/US ) 
66, 70, 79-104
 
 
38
 
 
Chronic Pain Coping Inventory (CPCI) 
 
  x x 
Painful 
hip/knee OA 
n=1 (1=US) 
 
105
 
39
 
Coping Orientation to Problems 
Experienced (COPE) inventory† 
- Religious coping subscale 
 
  
 
x 
 
 Knee OA 
n=1 
(1=US) 
36
 
35
 
Coping Strategies Inventory (CSI)   x x x Knee OA 
n=1 
(1=US) 
36
 
40
 
Coping Strategies Questionnaire 
(CSQ)† 
 
 
 
x 
 
x 
 
 
Hand/hip/knee 
OA, painful 
knee OA, 
painful 
advance knee 
OA, hip/knee 
n=24 
(1=Spain, 1=UK, 
21=US, 
1=Australia/Canada
51, 70, 71, 74, 79, 
83, 84, 86-88, 95, 
97, 101, 102, 104, 
106-114
 
41
 
 32 
 
OA /US) 
 
 
Daily Coping Inventory (DCI)  
 
x x x 
Knee OA, 
hand/hip/knee 
OA 
n=4 
(4=US) 
 
108, 109, 115, 116
 
 
42
 
Fear Avoidance Beliefs Questionnaire 
(FABQ)‡ 
-physical activity subscale  
x 
 
x 
 
Knee OA, 
hip/knee OA 
n=4 
(3=Netherlands, 
1=US) 
 
 
59, 76, 117, 118
 
 
 
43
 
Keefe’s Pain Behavior Observation 
Protocol (Keefe’s method)†   x  
Knee OA, 
hip/knee OA 
n=12 
(7=US) 
51, 52, 95, 104, 
106, 110, 111, 117-
120
 
 
51, 60
 
Knee Osteoarthritis Fears and Beliefs 
Questionnaire (KOFBeQ)†  x   Knee OA n=1(1=France) 
50
 
50
 
Illness Perceptions Questionnaire (IPQ) 
 
x 
 
x 
 
  
Knee pain, 
hip/knee 
pain/OA 
n=2 
(1=Netherlands, 
1=UK) 
 
 
121, 122
 
 
 
44, 45
 
 
Pain Catastrophizing Scale (PCS)  x   
Knee OA, 
Severe knee 
OA, advance 
hip/knee OA 
n=8 (1=Canada, 
1=Japan, 6=US) 
100, 115, 116, 123-
126
 
46
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Pain-Coping Inventory (PCI)†    
 
 
x 
 
 
x 
 
x 
 
 
Early painful 
knee OA, hip/ 
knee OA, OA- 
related knee/ 
hip symptoms 
n=12 
(1=France, 
10=Netherlands, 
1=Nigeria)   
 
 
76, 117, 127-136
 
 
47
 
Pain Behaviors for Osteoarthritis 
Instrument for Cognitively Impaired 
Elders (PBOICIE)† 
 
  
x 
 
Knee/hip OA 
n=1 
(1=US) 
52
 
52
 
Questionnaire to Identify Knee 
Symptoms (QuIKS)† x x 
 
x 
 
x 
OA-like knee 
pain 
n=2 
(2=Canada) 
 
37, 137
 
 
37
 
Survey of Pain Attitudes (SOPA)-35 
-Control Subscale 
x x x 
 
Knee OA 
n=1 
(1=Taiwan) 
66
 
48
 
Ways of Coping Scale (WAYS)  x x x Knee pain 
n=1 
(1=Canada) 
138
 
13, 49
 
* The measures are listed in alphabetical order.  
† Measure that have been validated in the target population. A brief 6-item version of the ASES has been validated in the target sample. 
‡ Only the subscales indicated were charted for each of these measures. 
Note: All the self-report questionnaires except the DCI, PBOICIE and QuIKS have been translated and/or validated in languages other than English. 
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As depicted in Figure 2.2, the coding of the items in the measures indicates that monitor 
body was represented in 5 (31%) of the 16 measures, and define and interpret symptoms in 
11 (69%), take remedial action in 12 (75%) and utilize sources of help in 5 (31%). Of the 
16 measures, only the QuIKS included all four components of illness perception and 
behaviour.37  
The inter-rater agreement for the coding of the items in the validated measures included 
before consultation were: a kappa of 0.43 for utilize sources of help, 0.51 for take remedial 
action, 0.56 for monitor body and 0.68 for define and interpret symptoms. The consensus 
discussion resulted in complete agreement between the two reviewers. 
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Figure 2.2 Chart showing the frequency of the four components of illness perception 
and behaviour among the charted validated measures as used in the publications. 
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2.4.3 Measures identified 
The measures identified were originally developed to measure illness beliefs, coping 
strategies/skills/styles, pain behaviour, or self-efficacy. The measures vary in length, and 
are self-administered questionnaires,35,37-50 except for two that are observation-based.51,52 
Most have been used many times to assess general and condition-specific populations and 
have been validated over many versions and in many languages, but further details are 
beyond the scope of this study. Table 2.2 provides a summary of the publications that used 
the identified measures. Below is a brief description of each measure, listed in alphabetical 
order. 
The Arthritis Self-Efficacy Scale (ASES) is a 20-item 3-subscale (pain, function, and other 
symptoms) self-report questionnaire.38 It was developed in the US in 1987 to evaluate the 
beliefs individuals with arthritis have about their ability to cope with the consequences of 
chronic arthritis.38 Its initial psychometric validation used attendees of an arthritis self-
management course.38  We coded the ASES as capturing the define and interpret symptoms 
component.  
The Chronic Pain Coping Inventory (CPCI) was developed in the US in 1995.39 It was 
validated as a measure of behavioural coping strategies (illness-focus, wellness-focus, and 
other) that could be addressed in multidisciplinary treatment pain programs using people 
with chronic pain problems.39 Two versions were developed: a patient self-report version 
(65 items) and a significant-other observation version (52 items).39 The patient version has 
11 dimensions (guarding, resting, asking for assistance, relaxation, task persistence, 
exercise/stretch, seeking social support, coping self-statements, opioid medication use, non-
steroidal use, and sedative-hypnotic use).53 The significant-other version lacks the 
dimension for coping self-statements.53 After excluding item 65, which covers three 
dimensions of medication use, the CPCI retained eight subscales.53 The psychometric 
properties of this 8-subscale version have been further validated in studies using samples of 
people attending multidisciplinary pain treatment programs.54-56 We coded the measure as 
take remedial action and utilize sources of help. 
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The COPE inventory is a 60-item 14-subscale self-report questionnaire about coping 
strategies and styles.35 Its theoretical underpinning are a behavioural self-regulation as well 
as Lazarus’ model of stress.35,42 The COPE was initially developed and validated in the US 
in 1989 using samples of undergraduate students.42 Its 14 subscales are: active coping, 
planning, suppression of competing activities, restraint coping, seeking social support-
instrumental, seeking social support-emotional, positive reinterpretation and growth, 
acceptance, turning to religion, focus on and venting of emotion, denial, behavioural 
disengagement, and alcohol-drug disengagement.35 Thirteen of its scales  measure emotion-
focused, problem-focused, and dysfunctional coping responses.35 The present review coded 
the COPE religious coping subscale as take remedial action.  
The Coping Strategies Inventory (CSI) is a 72-item 14-subscale self-report questionnaire 
about coping strategies. It was developed and validated in the US in 1985 using samples of 
undergraduate students.40,57 Its 14 subscales are arranged hierarchically into eight primary 
factors (problem solving, cognitive restructuring, express emotion, social support, problem 
avoidance, wishful thinking, self-criticism, and social withdrawal), four secondary factors 
(problem- and emotion-focus engagement and problem- and emotion-focus disengagement) 
that capture problem/emotion-focus coping and two tertiary factors (engagement and 
disengagement) that capture approach/avoidance coping.40 Twenty-three of its items are 
from the Ways of Coping Scale (WAYS).13,57 The CSI was coded as capturing all the 
components except monitor body. 
The CSQ is a 48-item questionnaire that records cognitive and behavioural coping 
strategies.41 Its original version divided the items into three factors (cognitive coping and 
suppression, helplessness, and diverting attention and praying).41 It was developed in the 
US in 1983 using data from 61 subjects with chronic low back pain.41 The majority of CSQ 
items were coded as take remedial action, and a few were coded as define and interpret 
symptoms.  
The Daily Coping Inventory (DCI) is a self-report questionnaire consisting of eight single-
item categories about coping.42 The DCI has an open item asking the respondent to state 
their ‘most bothersome event or issue of the day’ and eight closed appraisal items.42 It was 
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developed in the US in 1984 using samples of people in  the local community to measure 
cognitive and behavioural coping.42 In 1992, the DCI was adapted for assessing daily 
coping with chronic pain in seven categories: distraction, redefinition, direction action, 
relaxation, emotional expression, seek spiritual comfort, and seek emotional comfort.58 This 
newer version of the DCI attained construct validation using 75 adults with rheumatoid 
arthritis.58 We coded the DCI with all the components except monitor body. 
The Fear Avoidance Beliefs Questionnaire (FABQ) is a 16-item 2-subscale (physical 
activity and work) self-report questionnaire. It was developed in Scotland in 1993, and is 
based on theories of fear behaviour, avoidance behaviour, and illness behaviour.43 Its 
psychometric properties  were validated using patients with lower back pain and/or sciatica 
in a study of how one’s beliefs affect one’s physical activity and work.43 It has since been 
adapted for knee pathology.59  Only the ‘physical activity’ subscale of the FABQ was 
included and was coded as monitor body and utilize sources of help. 
The Illness Perception Question (IPQ) is a 38-item 5-subscale self-report questionnaire.45 It 
was theoretically-based on Leventhal’s self-regulation model of illness behaviour and was 
constructed to assess the five cognitive attributes of illness representation.16,22,45 It was 
developed in England and New Zealand in 1994 and was validated using samples of 
patients in England with diabetes, rheumatoid arthritis, asthma or undergoing dialysis, and 
patients in New Zealand with chronic fatigue syndrome, chronic pain, or myocardial 
infarction.45 Only some samples were used for evaluating each psychometric property.45 To 
correct minor psychometric problems in two subscales and add additional subscales which 
would also cover emotional representation, a  revised version (IPQ-R) was developed in 
2002 using eight different illness groups.44 The IPQ-R consists of three sections. We 
included section two, which is a 38-item 7-dimension measure of timeline acute/chronic, 
timeline cyclical, consequences, personal control, treatment control, illness coherence, and 
emotional representations.44 We coded section two as monitor body and define and interpret 
symptoms. 
Keefe’s Pain Behavior Observation Protocol (Keefe’s method) is a 5-item observation-
based measure.60 It was developed and validated in the US in 1982 using a sample of 
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patients with back pain.60 In the original measure, people were asked to sit, recline, stand, 
walk, and shift, and the frequency of five concomitant behaviours were coded as pain 
behaviour items. For assessing people with knee OA pain, the five items were modified to 
guarding, active rubbing, unloading joints, rigidity, and joint-flexing.51  We coded all five 
items as take remedial action.51  
The Knee Osteoarthritis Fears and Beliefs Questionnaire (KOFBeQ) is an 11-item self-
report questionnaire that assesses an individual’s fears and beliefs about their knee OA.50 It 
was developed in 2013 in France using an empirical approach.50 Its psychometric properties 
were tested using a sample of 524 patients with radiographic knee OA.50 We coded the 
KOFBeQ as define and interpret symptoms. 
The Pain Behaviors for Osteoarthritis Instrument for Cognitively Impaired Elderly 
(PBOICIE) is a 6-item observation-based measure.52 It was developed and validated in the 
US in 2008 and  uses the activity protocol from the Keefe’s method but applies a different 
set of  6 items (excessive stiffness of the affected joint during activities other than walking, 
shifting weight when seated, massaging affected area, clutching or holding onto affected 
area, rigid and tense body posture, and clenching teeth).51,52 A 10-item version was 
evaluated in a sample of 32 non-cognitively impaired elderly with knee or hip OA, which 
resulted in the 6-item PBOICIE.52 We coded the PBOICIE as take remedial action. 
The Pain Catastrophizing Scale (PCS) is a 13-item 3-subscale (rumination, magnification, 
and helplessness) self-report questionnaire about exaggerated negative affect towards 
pain.46, 61 It was developed in Canada in 1995 for clinical and non-clinical populations and 
includes five items from the catastrophizing subscale of the CSQ.41,46,62 It was initially 
validated  in a series of four studies, of which three used samples of undergraduate students 
and the other used a sample of people undergoing an electro-diagnostic evaluation.46 Its 
psychometric properties were then confirmed using a sample of undergraduate students.63  
The PCS was coded as define and interpret symptoms. 
The Pain-Coping Inventory (PCI) is a 33-item self-report questionnaire that records 
individuals’ cognitive and behavioural pain coping strategies.47,64 The original paper on its 
development was a 1996 publication from the Netherlands and is not available in English.47 
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A follow-up publication in 2003 confirmed its psychometric properties using patients with 
chronic pain conditions.64 The conditions specified were rheumatoid arthritis, fibromyalgia, 
and several location-specific pain syndromes, although they are not specific to the knee.64 
The PCI has two second-order factors that cover six first-order factors: active pain coping 
(transformation, distraction, and reducing demands) and passive pain coping (retreating, 
worrying, and resting).47,64  The items of the PCI, similar to the CSQ, were predominantly 
coded as capturing take remedial action. The PCI also had a few items coded as monitor 
body and define and interpret symptoms. 
The QuIKS is a 13-item 4-subscale self-report questionnaire focused on identifying early 
symptomatic knee OA problems in order to inform conservative intervention.37 It was 
developed in Canada, in 2013, using an empirical approach.37 It demonstrated internal 
consistency in a sample of people between 40 and 65 years of age with knee pain consistent 
with knee OA.37 Its four subscales are: medication [use], monitoring [of knee symptoms], 
interpreting [ongoing knee symptoms], and modifying [activities in response to knee pain]. 
The QuIKS was coded as having all four components of illness perception and behaviour. 
The Survey of Pain Attitudes (SOPA) underwent preliminary development and 
psychometric evaluation as a 24-item 5-subscale measure of pain-related beliefs in the US 
in 1986.53 However, the development and validation of its original 57-item 7-subscale (pain 
control, disability, harm, emotion, medication, solicitude, and medical cure) version was 
informed by cognitive behavioural models and used 241 patients with chronic pain (17% 
had lower extremity pain, but the knees were not specified).65 Subsequently, a 35-item 
version (SOPA-35) was published in 1999.48 The SOPA-35 has the same seven subscales, 
and was developed and underwent validation using patients with chronic pain in several 
body locations, not specifying the knees.48 In the present review, we included only the 
control subscale of the SOPA-35 which we coded as all the components except utilize 
sources of help.48,66  
The WAYS is a 66-item self-report questionnaire, whose theoretical underpinning is the 
coping and stress theory, was developed by Lazarus and Folkman (1984) to record coping 
and behaviour strategies.13,67  Only 50 items are used for scoring. Analyses using a sample 
 41 
 
of 150 community dwelling adults derived eight subscales: confrontive coping, distancing, 
self-controlling, seeking social support, accepting responsibility, escape-avoidance, planful 
problem solving, and positive reappraisal.49  Most items were coded as take remedial 
action, a few items were coded as define and interpret symptoms, and as utilize sources of 
help (particularly, the items of the seeking social support subscale).  
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Table 2.2 Summary of publications that used the identified measures 
Author/ 
Year 
Country 
 
Sample* Aim/Question Relevant 
validated 
measure 
Methodology Measure-
Variable 
Type 
Results 
Clark et al. 
( 2014) 37 
Canada 105 OA-like knee 
pain 
Develop QuIKS as a 
screening tool for 
early knee OA 
QuIKS Cross-
sectional 
Independent  Subscales have 
adequate internal 
consistency 
Golightly et al. 
(2014) 108 
 
 
US 153 hand/hip/knee 
OA (82=knee) 
Examine associations 
between pain coping 
strategies and daily 
pain diary-based 
measures 
DCI and CSQ Longitudinal  Independent  Pain coping strategies 
related to maximum 
pain and pain range 
Hiramatsu et al. 
(2014) 123 
Japan 12 knee OA, 11 
healthy 
Examine cerebral 
responses to 
experimental pain 
PCS Cross-
sectional 
(Case-control) 
Independent    3 dimensions of 
catastrophizing (PCS) 
were significant 
different between 
groups. 
Holla et al. 
(2014) 130 
Netherlands 828 painful early 
knee OA 
Examine predictors 
and outcomes of 
avoidance of 
activities using the 
PCI 5-year 
Longitudinal  
Mediator Knee pain/Vitality 
predicted pain-related 
avoidance of activity 
(PCI) which predicted 
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avoidance model  activity limitations. 
Marcum et al. 
(2014) 79 
US 190 painful 
advanced knee 
OA 
Evaluate correlates of 
gait speed 
ASES, CSQ 
(catastrophizing 
subscale) 
Cross-
sectional 
 Independent Functional self-efficacy 
(ASES) and opioid use 
were independently 
associated with gait 
speed.   
Marks 
(2014) 80 
US 17  knee OA, 
women 
Find factors 
contributing to 
perceived impact of 
condition 
ASES (Pain and 
Other symptoms 
subscales) 
Cross-
sectional 
Mediator Pain efficacy (ASES) 
mediated ambulatory 
capacity 
Pisters et al. 
(2014) 128 
Netherlands 288 hip/knee OA 
(216 knees) 
Evaluate mediating 
role of reduced 
muscle strength 
between avoidance of 
activity and 
limitations  
PCI (resting 
subscale) 
5-year 
Longitudinal  
Independent  Reduced knee extensor 
muscle strength 
mediated avoidance of 
activity (PCI) effect on 
limitations  
Rayahin et al. 
(2014) 81 
US 212 knee OA Which psychosocial 
factors were each 
associated with good 
pain experience 
outcome? 
ASES and PCS 2-year 
Longitudinal 
Independent Higher self-efficacy 
(ASES) and pain 
catastrophizing(PCS) 
were associated with 
good outcome 
Skou et al. Denmark 79 non-acute 
hip/knee pain 
Identify predictors of 
effectiveness of 
ASES 1-year 
Longitudinal 
Independent Self-efficacy predicted 
pain and quality of life. 
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(2014) 82 
education and 
exercise 
Smink et al. 
(2014) 132 
Netherlands 313 painful 
hip/knee OA 
Which factors relate 
to health care use 
after stepped-care 
strategy? 
PCI 36-week 
Longitudinal  
Independent Active coping style 
(PCI) determinant  of 
health care use, but not 
statistically significant 
Wideman et al. 
(2014) 124 
US 107 knee OA Does sensitivity to 
physical activity 
predicts 
psychological factors, 
response to 
quantitative sensory 
testing, and OA-
related outcomes? 
PCS Cross-
sectional 
Dependent 
(Outcome) 
Along with other 
variables, 
catastrophizing (PCS) 
predicted walking 
performance, self-
reported pain and 
physical function  
Alschuler et al. 
(2013) 71 
US 797 painful knee 
OA 
Are pain coping skills 
prognostic factor of 
pain/function 
changes? 
CSQ 1-year 
Longitudinal  
Independent 
(Predictor) 
Constructs in CSQ were 
prognostic of pain and 
function 
Benhamou et al. 
(2013) 50 
France 524 knee OA Develop measure of 
fears and beliefs held 
by patients with knee 
OA 
KOFBeQ Cross-
sectional 
Independent Reliable, and obtained 
content and construct 
validation 
Bolaji et al. Nigeria 215 painful Explore difference in PCI Cross- Dependent Passive coping (PCI) 
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(2013) 133 
hip/knee OA (83 
knees, 71 both) 
pain coping strategies 
between genders 
sectional was higher in males, 
and related to poorer 
pain, depression, and 
physical activity 
Cruz-Almeida et 
al. 
(2013) 114 
US 194 knee OA Identify psychology 
profile relationship 
with pain and sensory 
CSQ Cross-
sectional 
Dependent Lower scores on passive 
dimension of CSQ 
related to higher 
optimism  
Hamilton et al. 
(2013) 137 
Canada 105 knee pain Does activity-
modifying behavior 
mediates the 
relationship between 
the pain severity with 
physical function or 
knee-related quality 
of life? 
QuIKS 
(Modifying 
subscale) 
Cross-
sectional 
Mediator  activity-modifying 
behavior (QuIKS) 
mediated pain severity 
effect on physical 
function and quality of 
life  
Hunt et al. 
(2013) 83 
Canada/US/
Australia 
20 knee OA Feasibility of a 
physiotherapist-
delivered treatment 
protocol combining 
exercise and Pain 
Coping Skills 
Training 
CSQ, ASES Intervention 
(Randomized 
Control Trial) 
Dependent Exercise with but not 
without Pain Coping 
Skills Training 
improves pain coping 
(CSQ). Both improved 
self-efficacy (ASES) for 
control of pain 
management  
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Riddle and 
Jensen  
(2013) 107 
US 873 painful knee 
OA 
Does the two-item 
per subscale version 
of CSQ 
have construct 
validity? 
CSQ (2-item per 
subscale 
version) 
Cross-
sectional  
Independent  Construct validity was 
generally supported 
(strongest for 
Catastrophizing and 
Praying and Hoping 
subscales), criterion 
validity depended on 
criterion 
Weiner et al. 
(2013) 84 
US 190 painful 
advanced knee 
OA 
What is the efficacy 
of periosteal 
stimulation as a 
treatment? 
ASES, CSQ 
(catastrophizing 
subscale) 
Intervention 
(Randomized 
Control Trial) 
Independent Lower self-efficacy 
(ASES), depressive 
symptoms, higher 
difficulty with daily 
activity predicted lower 
likelihood of response 
Holla et al. 
(2012) 127  
 
 
  
Netherlands 151 painful early 
knee OA 
Is the avoidance 
model valid? 
PCI Cross-
sectional 
Mediator  Avoidance (PCI) 
mediated pain /negative 
affect effect on lower 
muscle strength. 
Avoidance predicted 
activity limitations. 
Murphy et al.   US 44 painful 
hip/knee OA 
Evaluate how coping 
strategies relate to 
CPCI Cross-
sectional 
Moderator Guarding (CPCI) 
related to lower levels 
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(2012) 105 
symptoms and 
physical activity 
patterns 
of activity. Asking for 
Assistance (CPCI) 
related to higher levels 
of activity. Resting 
(CPCI) moderated 
pain’s association with 
activity. Guarding, 
Resting, Task 
Persistence, and Pacing 
(CPCI) moderated 
fatigue’s association 
with activity 
Pisters et al. 
(2012) 131 
Netherlands 288 hip/knee OA 
(216 knees) 
Describe the course 
of limitations in 
activities over 5 years 
of follow-up and 
identify predictors of 
future limitations in 
activities  
PCI (resting 
subscale) 
5-year 
Longitudinal  
Independent  Avoidance of activities 
predicted future activity 
limitations 
Skou et al. 
(2012) 85 
Denmark 36 hip/knee OA-
related pain 
Feasibility of early 
multimodal non-
surgical treatment 
ASES 3-month 
Longitudinal   
Dependent  Significant 
improvement on ASES 
Somers et al. 
(2012) 86 
US 232 knee OA, 
overweight/obese 
Efficacy of pain 
coping skills training 
ASES and CSQ 
(catastrophizing 
Intervention 
(Randomized 
Dependent Significant difference in 
improvements in self-
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and lifestyle 
behavioral weight 
management 
interventions 
subscale) Control Trial) efficacy between groups 
Broderick et al. 
(2011) 70  
US 171 painful 
hip/knee OA 
What are the 
predictors of 
treatment 
expectation? 
ASES and CSQ Cross-
sectional 
Independent Better adaptive coping 
(CSQ) associated with 
better self-efficacy 
(ASES), quality of life, 
and psychological 
function  
Van Dijk et al. 
(2011) 129 
Netherlands 237 hip/knee OA 
(174=knee) 
Do psychological and 
social factors predict 
activity limitations? 
PCI Longitudinal  Independent Not independent 
predictor of activity 
limitations 
Wade et al. 
(2011) 125 
US 310 severe knee 
OA 
What is the 
relationship between 
pain catastrophizing 
and 3-stage model of 
pain processing? 
PCS Cross-
sectional 
Mediator   Pain catastrophizing 
(PSC) mediated pain 
unpleasantness effect on 
suffering 
Wu et al. 
(2011) 66 
Taiwan  205 knee OA Effectiveness of a 
self-management 
program 
ASES and 
SOPA-35 (pain 
control 
subscale) 
Intervention 
(Treatment-
Control Trial) 
Dependent   Pain beliefs (SOPA-35) 
and self-efficacy 
(ASES) improved by 
program 
Gandhi et al. Canada 200 advance Impact of mental PCS Cross- Independent Pain catastrophizing 
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(2010) 126 hip/knee OA health symptoms and 
catastrophizing on 
scores of function, 
quality of life, and 
pain 
sectional (PSC) predicted lower 
function, quality of life, 
and pain 
Holla et al. 
(2010) 134 
Netherlands 1002 early OA-
related knee/hip 
symptoms 
Predict 2-year course 
of activity limitations 
PCI  2-year 
Longitudinal  
Independent  Pain coping strategy 
(PCI) associated with 
higher activity 
limitations 
Izal et al. 
(2010) 74 
Spain 104 OA (61.5% 
knee) 
Role of coping 
strategies in 
disagreement 
between radiographic 
damage and function 
CSQ Cross-
sectional 
Moderator Certain pain coping 
strategies (CSQ) 
explain disparity 
between joint damage 
and functional 
impairment 
Mcknight et al. 
(2010) 87 
US 254 early knee 
OA 
Effect of coping self-
efficacy and 
catastrophizing on 
physical function 
ASES and CSQ 
(catastrophizing 
subscale) 
9-month 
Longitudinal 
ASES=Medi
ator, 
CSQ=Indepe
ndent 
Self-efficacy (ASES) 
mediated pain 
catastrophizing (PCS) 
effect on physical 
function 
Peat and 
Thomas 
(2009)139 
UK  285 knee pain Describe the changes 
of appraisal and 
behavior that 
accompanies 
CSQ (1 item per 
subscale 
version) 
18-month 
Longitudinal 
 Worsen of pain was 
accompanied by 
increased 
catastrophizing, praying 
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worsening of knee 
pain 
and hoping (CSQ), pain 
frequency/extent, 
depressive symptoms, 
medication use, and 
functional limitations 
Scopaz et al. 
(2009) 118 
US 182 knee OA Are psychological 
variables associated 
with physical 
function? 
FABQ (physical 
activity 
subscale) and 
Keefe's method 
Cross-
sectional 
Independent Higher fear avoidance 
beliefs (FABQ) and 
anxiety related to poorer 
physical function 
Jones et al. 
(2008) 88  
UK 939 hip/knee OA Examine the 
relationship between 
race and pain coping 
strategies 
ASES (pain 
self-efficacy and 
function self-
efficacy 
subscales) and 
CSQ 
Cross-
sectional 
Dependent   Race associated with 
hope and praying (CSQ) 
but not self-efficacy 
(ASES) 
Perrot et al. 
(2008) 135 
France 4,719 hip/knee 
OA (2781=knee, 
385 = both) 
Study pain coping 
strategies, and 
evaluate the French 
version PCI 
PCI Cross-
sectional 
Dependent  More passive coping 
with longer duration of 
OA. Supported 
structural and other 
validation criteria of 
PCI 
Shelby et al. 
(2008) 100  
US 192 knee OA Does self-efficacy 
mediate pain 
catastrophizing effect 
ASES, PCS Cross-
sectional 
ASES= 
Mediator 
Self-efficacy was a 
significant mediator 
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on pain and 
disability? 
PCS= 
Independent 
Somers et al. 
(2008) 113 
US 43 painful knee 
OA, borderline 
morbidly/morbidl
y obese 
Does pain 
catastrophizing relate 
to pain and 
adjustment? 
CSQ 
(catastrophizing 
subscale) 
Cross-
sectional 
Dependent Higher pain 
catastrophizing (CSQ) 
associated with less 
pain, higher binge 
eating, and lower eating 
self-efficacy. 
Tsai et al. 
(2008) 52 
US 7 cognitively 
impaired elder, 
then 32 elders 
with hip/knee OA  
Develop and do 
psychometric testing 
of PBOICIE 
Keefe's method, 
PBOICIE 
Cross-
sectional 
Dependent  PBOICE significantly 
associated with Keefe's 
method, discriminate 
pain behaviors before 
and after analgesic use. 
Internal consistency not 
acceptable  
Wright et al. 
(2008) 89 
US 275 early knee 
OA 
Which psychological 
factors with disease 
severity factors best 
account for levels of 
pain and function? 
ASES 24-month 
Longitudinal  
Mediator Higher self-efficacy 
mediated resilience 
effect on lower pain and 
better physical function 
Fraenkel et al. 
(2007) 140 
US 105 OA-like knee 
pain 
Efficacy of a 
computer tool to 
improve  informed 
ASES  Intervention 
(Randomized 
Control Trial) 
Dependent  Self-efficacy (ASES) 
higher with intervention 
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decision-making 
Maly et al. 
(2007) 90 
Canada 54 knee OA Does self-efficacy 
mediate the effect of 
age, psychosocial, 
impairment, and 
mechanical factors on 
walking 
performance? 
ASES (function 
subscale) 
Cross-
sectional 
Mediator Self-efficacy (ASES) 
mediated age and 
strength but not 
depressive symptoms 
and obesity on walking 
impairment 
Marks  
(2007) 91 
US 100 painful knee 
OA 
Examine strength of 
the relationship 
between walking 
ability and certain 
psychological factors  
ASES Cross-
sectional 
Independent Higher self-efficacy 
associated with lower 
pain, exertion during 
walking, and depression 
scores 
Botha-
Scheepers et al. 
(2006) 122 
Netherlands 316  hip/knee 
pain/OA 
Is the association 
between impairments 
and activity 
limitations modified 
by illness perception 
and mental health?  
IPQ (revised 
version IPQ-R) 
Cross-
sectional 
Moderator Construct in IPQ-R had 
modifying effect on the 
association 
Emery et al. 
(2006) 116 
US 62 knee OA Relationship between 
baseline pain coping 
and pain 
catastrophizing on 
changes in 
DCI and PCS Cross-
sectional 
Independent Higher pain 
catastrophizing (PCS) 
predicted lower state 
anxiety 
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nociceptive threshold, 
pain rating, and 
anxiety following 
coping skills training 
Maly et al. 
(2006) 99 
Canada 54 knee OA Determine factors 
related to self-
efficacy for physical 
task 
ASES (Function 
subscale) 
Cross-
sectional 
Dependent 51 % of variance in 
functional self-efficacy 
(ASES) explained by 
knee stiffness, 
hamstrings strength, 
age, depression scores, 
but by not pain, anxiety, 
joint space, and body 
weight. 
Mitchell et al. 
(2006) 121 
UK 231 knee pain Investigate treatment 
of knee pain in 
primary care 
IPQ Cross-
sectional 
Independent  Illness beliefs (IPQ) 
predicted consultation 
with GP and referral to 
rheumatology services 
Heuts et al. 
(2005) 92 
Netherlands 273 hip/knee OA Efficacy of self-
management program 
ASES (Function 
subscale) 
Intervention 
(Randomized 
Control Trial) 
Dependent Functional self-efficacy 
(ASES) improvement 
not significantly 
different between 
groups 
France et al. 
(2004) 115 
US 74 post-
menopausal 
Relationship between 
pain behavior, 
DCI, PCS Cross-
sectional 
Independent  More emotion-focus 
coping (DCI) or pain 
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women  knee OA 
and 58 aged-
match men 
hormone replacement 
therapy, and pain 
catastrophizing (PSC) 
related to more arthritis 
pain and less pain 
tolerance 
Harrison 
(2004)93 
US 50 knee OA Relationship among 
knee OA grade, pain, 
balance, and self-
efficacy 
ASES (function 
subscale) 
Cross-
sectional 
Independent Self-efficacy and pain 
accounted for 74% of 
variance in functional 
difficulty 
Keefe et al. 
(2004a) 109 
US 64 women and 36 
men with knee 
OA  
Gender difference in 
pain, mood, and pain 
coping 
CSQ 
(catastrophizing 
subscale and 
coping efficacy 
subscale) and 
DCI 
30-day 
Longitudinal  
Dependent   Problem-focus coping 
(DCI) used more by 
women. 
Keefe et al. 
(2004b) 101 
US 72 married 
patients with 
painful knee OA 
and their spouse 
Test separate and 
combined effects of 
spouse-assisted pain 
coping skills training  
and exercise training  
ASES and CSQ  Intervention  Dependent  Combined interventions 
improve pain coping 
(CSQ) and self-efficacy 
(ASES) 
Jensen et al. 
(2003) 102 
US 87  knee OA 
(from Keefe et al. 
1996)104 
Develop and validate 
brief versions of 
pain-related beliefs 
and coping scales 
ASES and CSQ Intervention 
(Randomized 
Control Trial) 
Dependent Brief versions of pain-
related belief (ASES) 
and coping strategies 
(CSQ) developed and 
validated. 
 55 
 
Sharma et al. 
(2003) 103 
 
US 257 knee OA Identify factors that 
predict poor physical 
function 
ASES (function 
subscale) 
3-year 
Longitudinal 
Independent Self-efficacy along with 
other variables 
protected against poor 
physical function scores 
Gaines et al. 
(2002) 94 
US 43 knee OA Determine 
relationship between 
arthritis self-efficacy 
and self-reported 
functional 
performance  
ASES Cross-
sectional 
Dependent Relationship between 
self-efficacy and 
function vary by gender 
Steultjens et al. 
(2001) 76 
Netherlands 190 hip/knee OA 
(119  Knee OA) 
Role of coping styles 
as prospective 
determinants of pain 
and disability 
FABQ (physical 
activity 
subscale) and 
PCI 
36-week 
Longitudinal  
Independent For knee OA, only 
resting (PCI) at baseline 
predicted disability at 
follow-up, and pain 
transformation (PCI) 
was determinant of 
pain. For hip, none 
significant. 
Hopman-Rock 
et al. 
(2000) 98 
Netherlands 56 knee/hip OA, 
49 controls 
Evaluate self-
management program 
ASES Intervention 
(Control Trial) 
Dependent Self-efficacy (ASES) 
significantly related 
group x time effect 
Rapp et al. US 394 knee pain Evaluate relationship CSQ Cross- Independent  Pain coping skills 
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(2000) 112 
between pain coping 
skills and disability 
sectional (CSQ) significantly 
associated with physical 
disability 
Keefe et al. 
(1999) 95 
US 88 painful knee 
OA 
Determine long-term 
effect of spouse-
assisted pain-coping 
skills training on 
several physical and 
psychological 
disability, pain-
coping and pain 
behavior 
ASES, CSQ, 
Keefe's method 
Intervention Independent/ 
Dependent  
Improved self-efficacy 
and coping at 6 months. 
Improved self-efficacy 
and pain behavior at 12 
months  
Hopman-Rock 
and Kraaimaat 
(1998) 136 
Netherlands 157 knee/hip pain 
in last month 
Investigate use of 
pain coping strategies 
by community-living 
elderly with hip/knee 
pain 
PCI Cross-
sectional  
Mediator  Pain coping (PCI) 
mediated pain 
chronicity effect on 
physical disability 
Sullivan et al. 
(1998) 96 
US 92 painful knee 
OA 
Are gains in function 
over 8-weeks 
sustained at 1 year 
follow-up? 
ASES (pain and 
other symptoms 
subscales) 
Intervention 
(Treatment-
Control) 
Dependent  Gains on both subscales 
were not significant 
between groups 
van Baar et al. 
(1998) 59 
Netherlands 201 hip/knee OA Determine 
effectiveness of 
exercise therapy 
FABQ (physical 
activity 
subscale) 
Intervention 
(Randomized 
Control Trial) 
Dependent Scores not different 
between intervention 
and control 
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Van Baar et al. 
(1998) 117 
Netherlands 200 knee/hip OA 
(112=knees) 
Examine the extent to 
which various factors 
affect pain and 
disability 
FABQ (physical 
activity 
subscale), 
Keefe's method, 
and PCI 
Cross-
sectional 
FABQ and 
PCI= 
Independent 
Keefe's 
Method= 
Dependent 
Retreating (PCI) 
predicted pain 
Keefe et al. 
(1997) 97  
US 130 knee OA Examine relationship 
between pain coping 
strategies and self-
efficacy  
ASES and CSQ Cross-
sectional 
CSQ= 
Independent 
ASES= 
Dependent  
Different coping 
strategies predicted 
lower/higher self-
efficacy 
Keefe et al. 
(1996) 104 
US 88 knee OA  Determine the effect 
of spouse-assisted 
pain-coping skills 
training several 
physical and 
psychological 
disability, pain-
coping and pain 
behavior 
ASES, CSQ, 
Keefe's method 
Intervention   Dependent    Improved psychological 
disability scores, self-
efficacy and certain 
copings strategies 
Blalock et al. 
(1995) 36 
US 300 knee OA Is there a relationship 
between coping 
strategies and future 
COPE and CSI 6-month 
Longitudinal  
Independent  Constructs in CSI were 
related to future 
psychological well-
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well-being? being 
Fry and Wong 
(1991) 138   
Canada 69 knee pain Determine the effect 
of matching pain 
management training 
and individual differ- 
ences on coping style  
WAYS Cross-
sectional 
Intervention Matches between 
coping styles (WAYS) 
with intervention types 
were effective 
Keefe et al. 
(1990a) 110  
US 99 knee OA Does cognitive-
behavioral 
intervention to 
improve pain coping 
skills reduce pain, 
physical and 
psychological 
disability, and pain 
behavior? 
Keefe's method 
and CSQ  
Intervention 
(Randomized 
Control Trial) 
Independent  Pain-coping skills 
training had improved 
pain and psychological 
disability scores 
Keefe et al. 
(1990b) 111 
US 99 knee OA 6 months follow-up 
of pain-coping skills 
training 
Keefe's method 
and CSQ  
Intervention 
(Randomized 
Control Trial) 
Independent  Deterioration in gains in 
psychology ability, and 
trend towards 
improvement in 
physical ability 
Keefe et al. 
(1987a) 51 
US 87 painful knee 
OA 
Provide descriptive 
data on behavior 
patterns and 
functional 
Keefe's method 
and CSQ 
Cross-
sectional 
Independent Guarded movement 
(Keefe's Protocol) was 
most frequent pain 
behavior. Pain control 
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impairment  and rational thinking 
(CSQ) were predictive 
of functional 
impairment 
Keefe et al. 
(1987b) 106 
US 51 painful knee 
OA 
Determine the 
relationship between 
coping strategies and 
pain, health status, 
and psychological 
distress 
CSQ Cross-
sectional 
Independent Coping attempts, pain 
control and rational 
thinking (CSQ) 
accounted for 60% of 
variance in CSQ scores. 
Higher pain control and 
rational thinking 
predicted better pain, 
health status, and 
psychological distress 
scores. 
*Most samples composed of older adults, usually aged ≥40 year or ≥50 years. 
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2.5 Discussion  
To our knowledge, this is the first attempt to identify and analyse the content of published 
validated measures that can be interpreted as capturing components of illness perception 
and behaviour in people who have knee pain/OA. The primary finding was that most 
existing measures did not capture all four components of illness perception and 
behaviour.37 The one that did, the QuIKS, was the most recently developed of all the 
measures. The QuIKS is one of only seven measures identified in this review that have 
been validated using people with knee pain/OA, see Table 2.1.37  
Our findings demonstrated that most of the included measures do not operationalize all 
four components of illness perception and behaviour. The validated measures focus more 
on capturing take remedial action. This seems to be reflective of several measures 
capturing cognitive and/or behavioural coping strategies, including the COPE, CPCI, CSQ, 
CSI, DCI, and PCI.39-42,47  Conversely, only 31% of the measures were identified to have 
items that capture monitor body or utilize sources of help. One could argue that utilize 
sources of help is a very unique concept and that our search was aimed at support-seeking 
rather than the support literature. However, other questionnaires fitting this concept did 
come up in our search, but they did not have an individual-level scoring method,68 were 
open-ended questions, were checklists, or were comprised of a single question about the 
number of visits to a clinician.66,69  
We included only one subscale from each of the COPE, FABQ and SOPA-35 because that 
was the portion of these questionnaires used in the included publications. The other items 
of these measures could be explored to determine how comprehensively each full measure 
operationalizes the concept of illness perception and behaviour. The suitability of the full 
version of these measures might vary with clinical scenarios, such as the temporal 
dimensions of a person’s condition, and with the measurement purpose, such as for 
diagnosis, evaluation, or prognosis. Therefore, future research could investigate the validity 
of the full version of these measures for use in assessing people who have knee pain/OA.  
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With respect to our findings, it can be reasoned that scores on validated measures that are 
missing components of illness perception and behaviour provide an incomplete description 
and insight into an individual’s response to his or her symptoms.18 The measures identified 
have been previously demonstrated to be predictive of pain level, disability, activity 
limitations, psychological functioning (e.g. depression) and physical functioning in the 
target population.36,70,71 Particularly, the ASES and CSQ have been richly used in many 
roles as independent, mediator, moderator, and dependent variables in studies on the target 
population, see Table 2. A measure covering the four components may provide sufficient 
information regarding a person’s response to their knee pain/OA to adequately inform 
therapy. 
While the QuIKS captures all four components, it has only undergone content validation 
and had its internal consistency confirmed in people with early symptoms of knee OA.37 
More aspects of validation are required to provide confidence that the QuIKS is 
psychometrically sound and related to physical and psychological adjustments to knee 
pain/OA. Alternatively, an additional measure capturing all four components of illness 
perception and behaviour could be developed by combining items from some of the 
included measures, and then validated for people with symptomatic knee OA.  
The assessment of illness perception and behaviour is applicable to the recognition of 
illness and the implementation of the medical management of disability.18,43,72 As noted by 
Sirri et al. (2013: p.79), illness behaviour is a concept that delineates “prognosis and 
therapeutic differences” among people with “deceptively” similar diagnoses.18  Therefore, 
illness perception and behaviour may become important in explaining the discordance 
between the pain symptoms and the biologic evidence of knee OA, such as was previously 
demonstrated using the CSQ.18,73,74 For example, patients with similar structural knee joint 
changes and pain levels may require different treatment approaches if their levels of illness 
perception and behaviour are different.75 Identifying illness perception and behaviour 
issues that clinicians should address, could help direct clinical resources such as patient 
education and structured interventions to improve an individual’s health.18  
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Caution is advised regarding the use of the identified measures in the target population 
where they have not undergone validation. Many of the measures were developed and have 
been validated in a sample that was not identified as including people with knee pain/OA.  
For example some were developed and validated using samples of undergraduate 
psychology students,35,46,64 general population from the community,49 and people with 
various chronic conditions.39,53 Also, whilst measures validated in populations affected by 
OA in other joints are likely applicable to knee OA, their psychometric properties might be 
different for people with knee OA.76 
 
2.6 Study limitations 
This review has some limitations. First, given the large variety of terms related to illness 
perception and behaviour, it is possible that relevant terms were missed. Therefore 
validated measures used with the target population may have been overlooked. Also, two 
measures were not included because they were not made available by the developer or 
publisher by the end of this study.77,78 Second, the definitions used for each of the four 
components of illness perception and behaviour were developed for this study.17 So, the 
focus was on responses to illness and not all the different factors that may shape illness 
responses (e.g., optimism and mastery). It is likely that there may be many more 
components and antecedents to illness perception and behaviour, such as psychological 
function (depression), anxiety and optimism. Alternate definitions could be considered for 
the four components, which would possibly change the coding of the included measures.   
 
2.7 Conclusions 
Several validated measures capture the components of illness perception and behaviour 
defined in this study, but most do not capture monitor body or utilize sources of help. Only 
the QuIKS captures all four components. We recommend that it undergo further validation 
of its psychometric properties in the target population.  
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Chapter 3 
3 Interval-level measure of illness perception and 
behaviour  
A version of this chapter is presently under review for publication in a peer-reviewed 
journal. 
3.1 Abstract 
Objective: The Questionnaire to Identify Knee Symptoms (QuIKS) was recently 
developed to promote activity by screening for key lived experiences (i.e., illness 
perception and behavior) in people with osteoarthritis (OA) –like knee pain. The main 
purpose of this study was to evaluate measurement properties of the QuIKS using Rasch 
analysis in a sample of people with knee pain symptoms consistent with symptomatic knee 
OA. 
Methods: This study used cross-sectional data. The sample included 200 people along the 
following knee health continuum: pain-free healthy knees (n=55) from a university 
community, knee pain with no knee OA diagnosis (n=111) from a university-affiliated 
medical clinic, and patients with surgeon-diagnosed symptomatic knee OA awaiting high 
tibial osteotomy (n=34) from a sports medicine surgical clinic. The 13-item QuIKS was 
evaluated for its factor structure, item- and person-fit, an item’s category response 
structure, differential item functioning, local item dependency, unidimensionality, and test 
precision. Subsequently, the QuIKS underwent known-groups analysis and convergent 
validity with the Knee injury and Osteoarthritis Outcome Score (KOOS). 
Results: In the QuIKS, each item’s category response structure was modified.  Local item 
dependency informed the formation of four testlets. This refined QuIKS obtained summary 
fit to the Rasch model, unidimensionality, reliability (person separation index = 0.82) and 
interval-level scoring. Subsequently, the Rasch-refined QuIKS (QuIKS-R) demonstrated 
excellent known-groups validity and good convergent validity with the KOOS (Spearman’s 
rho = 0.45-0.77). 
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Conclusions: The QuIKS-R provides interval-level quantification of illness behavior in 
people with knee pain symptoms consistent with symptomatic knee OA. Its scores may 
help clinicians to identify important issues to address in therapy for people with early 
symptoms of symptomatic knee OA. 
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3.2 Introduction 
Symptomatic knee OA is a chronic degenerative joint disease that leads to activity 
limitations, performance restrictions, and reduced quality of life.1-4 In the US, the lifetime 
risk of developing symptomatic knee OA is up to 23.9%, depending on one’s sex, age, and 
obesity status.3  The lived experience of knee pain in people with knee OA is considered to 
be a biopsychosocial phenomenon.4-8   
Studies have linked illness perception and behaviour to knee OA-related disability in the 
pre-diagnosis stage and early stages of knee OA, and in people with recently diagnosed 
symptomatic knee OA.4-8 Illness perception and behaviour can be considered to have four 
components, each component corresponding to a clause in the definition that follows. 
Using Mechanic’s (1986) definition of illness behaviour, illness perception and behaviour 
is defined as “the manner in which persons monitor their bodies, define and interpret their 
symptoms, take remedial action, and utilize various sources of help as well as the more 
formal health-care system”.9 Illness perception and behaviour is promoted as a health 
construct.10, 11 When operationalized, it can identify issues that clinicians should address 
with patients to facilitate management of symptoms.10, 11 
Quantifying illness perception and behaviour, whether adaptive or maladaptive, may be 
useful in facilitating early recognition and management of knee OA symptoms to aid in the 
delay or prevention of long term disability. Several generic measures of illness perception 
and behaviour exist.10, 11 These measures include the Illness Behavior Questionnaire, 
Symptoms Response Scale, Scale for the Assessment of Illness Behavior, and Illness 
Cognition Scale, to name just a few.11 No generic measure of illness perception and 
behaviour has been specifically validated for knee pain and knee OA. Thus, their 
application to knee pain problems is questionable. For example, the Illness Behavior 
Questionnaire assesses several dimensions of abnormal illness behaviour and is currently 
the most widely used of these measures.12, 13 While it has a strong focus on the affective 
and cognitive aspects of illness, it overlooks overt aspects which are more applicable to 
physical health management.10, 11 The concept of illness perception and behaviour has been 
operationalized as coping strategies in other measures, such as the commonly used Coping 
Strategies Questionnaire.10, 14 However, we searched the literature and found the measures 
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of coping strategies are limited in their coverage across the four components (i.e., full 
definition) of illness perception and behaviour. More specifically, these measures provide a 
fairly incomplete picture of a patient’s illness perception and behaviour. This limitation in 
these measures could affect a clinician’s ability to make an informed decision about the 
management of a patient’s knee pain and knee OA-related symptoms. On the other hand, 
the QuIKS was specifically developed for clinical use in assessing a patient’s responses to 
their knee pain and knee OA-related symptoms.15 Furthermore, the contents of the QuIKS 
covers all four components of illness perception and behaviour and could better identify 
important issues to address in therapy.    
The QuIKS is a 13-item self-administered discriminative questionnaire.15 It was developed 
using a mixed-methods approach, which aligns with  recommendations by Velozo et al. 
(2012) for scale development.16 First, its items were generated through grounded theory 
qualitative research using one-on-one interviews of people with recently diagnosed knee 
OA or undiagnosed symptoms consistent with knee OA.6 This was followed by a 
consensus of rheumatology experts, then item reduction and internal consistency 
evaluation.15 Velozo et al. also recommended using Rasch analysis to determine whether a 
measure captures a unidimensional construct.16 However, this last recommendation has not 
yet been conducted for the QuIKS and therefore is the main purpose of this paper. 
In Rasch analysis, observed data are expected to fit the probabilistic relationship within and 
between person estimates and item estimates as specified in the Rasch measurement 
model.17 Consequently, a questionnaire with data that fits the Rasch model has a 
unidimensional construct, thereby having interval-level measurement properties as 
recommended for questionnaire measures.16, 18, 19 The current study sought to evaluate the 
factor structure, the items’ category response structure, item- and person-fit, differential 
item functioning, local item dependence, overall fit, unidimensionality, and the test 
precision of the QuIKS using Rasch analysis. The secondary purpose was to subsequently 
evaluate the known-groups validity and the convergent validity of the Rasch-refined 
QuIKS. 
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3.3 Methods 
3.3.1 Design 
This study used cross-sectional data. We recruited subjects into three distinct groups along 
the following knee health continuum: pain-free healthy knees (HK), knee pain with no knee 
OA diagnosis (KP), and surgeon-diagnosed knee OA scheduled for high tibial osteotomy 
(pre-HTO).  Subjects in the HK group self-reported no knee pain in the past three years and 
were between the ages of 20-40 years. Subjects in the KP group had verbally complained 
of knee pain lasting two or more weeks to their family physician within the previous three 
years as recorded in their medical chart and were between the ages of 40-65 years. Subjects 
in the pre-HTO group were between the ages of 40-65 years. The prevalence of knee OA 
increases with age. Therefore, the HK group was younger than the two involved groups and 
less likely to have knee OA. The HK group was recruited (March 2011 to January 2012) 
from a university community through posted paper notices. The KP group was 
retrospectively collected from data collected (April to August 2009) through a university-
affiliated medical clinic using mailed questionnaires as previously described.15 The pre-
HTO group was prospectively collected (March 2011 to January 2012) through a 
university-affiliated sports medicine clinic using mailed questionnaires. Each subject had to 
be fluent in English to participate in this study. We excluded persons with gout, rheumatoid 
arthritis, chronic low back pain, foot or hip pain, major co-morbidities, previous knee 
arthroplasty, or high tibial osteotomy. These exclusion criteria helped to ensure that the 
knee pain and the illness experiences of the subjects were consistent with symptomatic 
knee OA. Ethics approval was granted by Western University’s Health Sciences Research 
Ethics Board, see Appendix B. Each participant provided written informed consent. 
 
3.3.2 Participants 
The total sample was 200 subjects along the knee health continuum. The HK, KP, and pre-
HTO group had 55, 111, and 34 subjects, respectively. 
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3.3.3 Outcome measures 
The sample descriptive data included sex, age, body mass index (BMI), affected knee 
(unilateral, bilateral, or none), family history of arthritis (yes or no), and history of knee 
injury (yes or no). To indicate the structural severity of knee OA, a single rater recorded the 
Kellgren and Lawrence grade from standard weight-bearing radiographs of each 
symptomatic knee in the pre-HTO group.20 A Kellgren and Lawrence grade of 0, 1, 2, 3, 
and 4, represented normal, doubtful, minimal, moderate, and severe knee (tibiofemoral) 
OA, respectively.20 
 
3.3.3.1 The QuIKS 
We analysed the QuIKS, but data were collected on its 35-item prototype questionnaire ( as 
in the initial validation of the questionnaire) to allow for consistency of data collection 
across the study groups.15 The QuIKS has 13 items and four subscales, and each item has a 
5-point rating scale. Each of its four subscales captures one or more components of illness 
perception and behaviour. Some items use an adjectival scale to quantify frequency (0 = 
never, 4 = always), while others use Likert responses ranging from strongly disagree (0) to 
strongly agree (4). The 3-item medication subscale captures medication usage to relieve 
knee pain, reflecting self-care and professional-guided care.  The 3-item monitoring 
subscale captures a person’s awareness of their knee symptoms, reflecting illness 
recognition and evaluation.21 The 4-item interpreting subscale captures one’s understanding 
of one’s symptoms, reflecting information and health-care seeking, and illness recognition 
and labeling.21 The 3-item modifying subscale captures an individual’s changes or intention 
to change engagement in activity in order to avoid progressive knee damage, reflecting the 
principles of selection of, optimization of, and compensation for activity engagement.22, 23 
However, since each subscale may be the operationalization of one or more components of 
illness perception and behaviour, combining these subscales into a single measure might 
reflect a higher-order construct of illness perception and behaviour. This higher-order 
construct would be expected to be unidimensional. When normalized, the summative total 
score of the subscales of the QuIKS varies from 0-100 (worst to best state). 
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3.3.3.2 The KOOS 
The KOOS is a 42-item knee-specific self-administered questionnaire.24 It captures health 
status in the following five subscales: pain, other symptoms, activities of daily living, sport 
and recreation function, and knee-related quality of life.24 The total score of each subscale 
was normalized to a 0-100 scale (extreme to no problems). The KOOS has been widely 
used and has demonstrated validity, reliability and responsiveness for adults of all ages 
with acute and chronic knee pain problems; i.e. knee injury and osteoarthritis.25, 26 The 
KOOS was chosen to demonstrate the convergent validity of the QuIKS because both 
measures have a similar target population.  However, the KOOS evaluates symptoms 
severity, function, activity, and quality of life, whereas the QuIKS evaluates the illness 
perception and behaviour related to one’s knee pain symptoms.   
 
3.3.4 Data analysis 
3.3.4.1 Sample characteristics 
Descriptive characteristics were summarized for the knee health groups. The Shapiro-Wilk 
test evaluated the normality of the data within each group of knee health. Factor analysis 
and Rasch analysis used only the KP and pre-HTO groups combined (n = 145), because 
scores within the HK group were extreme and would not contribute to these analyses. Most 
data analyses were performed with SPSS version 20.0 (SPSS Inc, Chicago, Illinois).  
 
3.3.4.2 Factor analysis 
As recommended by Tennant and Pallant (2006),27 Horn’s parallel analysis was performed 
to determine the number of factors to extract from the QuIKS prior to its Rasch analysis.27, 
28
 This determined whether the QuIKS had only a single dominant construct as required for 
proceeding to Rasch analysis.27  Horn’s parallel analysis uses principal components 
analysis (PCA) with Monte Carlo simulation to determine the number of factors in a 
dataset. It identifies the number of factors with an empirical eigenvalue greater than the 
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corresponding eigenvalue generated from 1000 random datasets at a 95% confidence 
level.28 Horn’s parallel analysis is more accurate than other forms of factor analysis, such 
as the eigenvalues-greater-than-one rule and the scree plot.28 Following parallel analysis, 
PCA with varimax rotation determined the percentage variance explained by each factor. 
 
3.3.4.3 Rasch analysis 
A Rasch analysis approach was used to evaluate the fit of the data collected by the QuIKS 
to the Rasch mathematical model.29, 30 The RUMM2030 software (RUMM Laboratories, 
Perth, Australia) was used, which is a sophisticated and widely used software that is 
specialized for Rasch analysis. An estimated minimum sample size of 144 subjects was 
adequate for Rasch analysis for items calibration with ± 0.05 logits at 95% confidence even 
if the scale is poorly targeted.31 However a minimum sample size of 100 subjects is 
considered to be adequate in most cases at this confidence level.31 
We hypothesized that the QuIKS would contain a unidimensional dominant construct, 
conceptualized as illness perception and behaviour that represented the key experiences 
consistent with symptomatic knee OA. We used the following 12 steps and previously 
published fit criteria for the Rasch model to investigate this hypothesis.30  
Step 1: to evaluate goodness-of-fit, the data were divided into two class intervals using the 
subjects’ total scores. Step 2: a Fishers Likelihood test was performed. If significant (P 
<0.05 with Bonferroni correction for the number of items), it would suggest that the partial 
credit model version of the Rasch model should be used.32 Step 3: data for misfitted 
subjects, those with residual values outside ±2.5, were removed to allow for an accurate 
estimation of the questionnaire’s measurement properties. Step 4: response categories of 
the individual items were expected to be sequentially ordered. Disorder occurred when any 
response category for an item always had less than 50% probability of being endorsed 
when compared to each adjacent response category. When disordered response categories 
were identified, the response structure of the rating scale was corrected by combining two 
or more adjacent response categories. Step 5: the fit of each item was evaluated. Items 
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misfitted the model if their residual value was above +2.5 and/or had a significant chi-
square (χ2, P < 0.05 with Bonferroni correction for the number of items in the 
questionnaire). Any misfitted item was deleted because it did not align with the construct 
captured collectively by the other items. All the preceding steps were iterative. 
Step 6: the remaining data were evaluated for summary fit with the Rasch model as defined 
by a non-significant item-trait interactive χ2 (P < 0.05 with Bonferroni correction), mean 
person- and mean item- residual value (standard deviation) of ~0 (~1).  Step 7: each item 
was examined for differential item functioning (DIF) across two subject characteristics 
considered clinically relevant to the experience of illness perception and behaviour: sex 
(male/female) and body mass index (i.e., BMI cut point obese [≥30 kg/m2]/not obese) using 
two separate two-way analysis of variance (ANOVA) procedures. In each two-way 
ANOVA, the two independent variables were the subjects’ overall construct estimate 
divided into two class intervals and a subject characteristic. Each item had one mean score 
for the subjects in each class interval which formed the dependent variable. An item with 
DIF does not provide consistent estimation of the construct across the categories of the 
subject characteristics for subjects with equal overall estimates.30 Step 8: item pairs with 
their residual correlation > 0.2 after mathematically removing the dominant construct, were 
considered to have displayed local item dependency, which means that those items were 
associated beyond the dominant construct in the questionnaire.33 Such items were 
combined into a testlet.33  
A testlet is a group of two or more very closely associated items that give a similar estimate 
of a subject’s level of the construct. Testlets are sub-constructs of a scale, whereas 
subscales may or may not be sub-constructs. Step 9:  the misfitting subjects’ data (from 
step 3) were re-entered and the changes to the QuIKS in step 1 to 6 were repeated. This 
allowed all subjects who fit the Rasch-refined QuIKS to be accounted for in the subsequent 
steps of Rasch analysis. Step 10: we formally evaluated whether the dominant construct 
was unidimensional.  
Unidimensionality is a vital component for interval-level measurement. In the context of 
testlets, the construct was the common variance (A) among the testlets.33, 34 Each subject 
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had an estimate generated for two exclusive sets of items, using the Smith method.35 The 
two estimates for each subject were then compared using an independent t-test.35 
Unidimensionality was confirmed if less than 5% of subjects had significant t-scores, as 
estimated by the lower bound of a binomial 95% confidence interval.30 Step11: reliability 
(or scale precision) was then evaluated using the Person Separation Index (PSI). A PSI 
value of 0.8 indicated the questionnaire can distinguish subjects in up to three levels of the 
dominant construct, which is the minimum acceptable level for a measurement scale.36 Step 
12: targeting of the sample by the refined QuIKS was evaluated. This step investigated 
whether the spectrum of the construct captured by the refined QuIKS covered the spread of 
the construct in the sample. Ideally, the difficulty thresholds of the items should be 
adequately spread to capture the quantity of construct in every subject. Statistically, this 
was indicated by a mean person estimate (standard deviation) of ~1 (~0) when the mean 
item estimate was zero on the same logit (log-odd units) scale of the dominant construct.  
Also in this step, the estimate of each testlet was determined. This allowed us to determine 
the hierarchical order of the testlets on the dominant construct based on their logit scores. 
Lower logit scores represented the tendency of an item or testlet to capture lower levels of 
the dominant construct. A floor effect and ceiling effect were 15% or more subjects with 
the maximum or minimum scores, respectively.37  If the QuIKS was adequately validated 
by Rasch analysis, we adapted a conversion formula,38 and transformed its summative total 
raw scores to interval-level scores. 
 
3.3.4.4 Confirmatory factory analysis 
This was performed to test the factor structure in the Rasch-refined QuIKS. Version 7.3 of 
the Mplus software (Muthén & Muthén, Los Angeles, California) was used.39  Model fit 
was evaluated using the following fit indices and cut-off criteria for adequate fit; 
comparative fit index (CFI, >0.90), the Tucker-Lewis index (TLI, >0.90), and the root-
mean-square error of approximation (RMSEA, <0.08).40   
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3.3.4.5 Known-groups analysis 
We hypothesized that the total scores from the Rasch-refined QuIKS would be significantly 
higher for the HK versus the KP group (n = 166), and higher for the KP versus the pre-
HTO group (n = 145) with at least a moderate effect size. The estimated sample size was 
52 subjects per group for a moderate effect size.41 We used the Kruskal-Wallis H test (the 
non-parametric version of a 1-way ANOVA) with the Mann-Whitney U test (the non-
parametric version of an independent t-test) for post-hoc testing because the data had a 
non-normal distribution. Effect size (r) from the Mann-Whitney test was calculated as r = 
z/√n and then converted to Cohen’s d = 2r/√(1 - r2), where z was the z-score value obtained 
from the Mann-Whitney test and n was the total sample used in the analysis.42 A Cohen’s d 
of 0.41 was considered small and the minimum effect size for a clinically relevant effect, 
1.15 and ≥2.70 were moderate and strong effects, respectively.43 The 95% confidence 
interval (CI) of Cohen’s d was calculated as d ± 1.96*Standard Error.44 
 
3.3.4.6 Convergent validity 
We hypothesized that a moderate correlation would be observed between scores on the 
Rasch-refined QuIKS and each subscale of the KOOS. This hypothesis was based on 
reasoning that the KOOS subscales should be moderately related to a measure that 
identifies responses to early symptoms of knee OA. Spearman correlation coefficients (rs) 
quantified these relationships. The HK group was excluded to prevent errors in rs that 
would be caused by their extreme scores. Moderate correlation of rs ≥ 0.5  supported 
convergent validity.45  This analysis required an estimated sample size of 129 subjects, 
calculated using an rs of 0.7 (95% CI = 0.5 to 0.9) at an alpha value of 0.05, which was 
adequately met by the present study sample.46 
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3.4 Results 
3.4.1 Sample characteristics 
Response rate was 63.0% for the  KP and pre-HTO group, and not applicable to the HK 
group.15 The sample characteristics are summarized in Table 3.1.  
 
3.4.2 Number of factors 
Table 3.2 shows the results of Horn’s parallel analysis. Only the first factor had an 
empirical eigenvalue (5.97) that was greater than the corresponding randomly generated 
eigenvalue (1.67). These results indicated a single factor solution for the QuIKS which 
explained 45.9% of the total variance in its score.    
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Table 3.1 Sample characteristics by study groups 
Characteristics                          Known Groups 
Healthy 
Knees, 
 
n = 55 
Knee Pain, 
 
n = 111 
Knee 
Osteoarthritis 
(pre-HTO), 
n = 34 
Knee Pain and 
pre-HTO, 
 
n = 145 
Age, years 
     mean (SD) 
 
24.7 (4.4) 
 
52.1 (6.8) 
 
48.9 (6.5) 
 
51.3(6.8) 
Sex 
     Female (%) 
 
35 (63.6) 
 
62 (55.4)* 
 
9 (36.0) 
 
71 (49.0) 
BMI, kg/m2 
     mean (SD) 
 
22.9 (3.1) 
 
28.1 (9.1) 
 
29.1 (4.7) 
 
28.3 (8.3) 
Affected knee 
     Unilateral (%) 
     Bilateral (%) 
     None (%) 
 
1(1.8) 
4 (7.3) 
50 (90.0) 
 
61 (55.0) 
49 (44.1) 
1 (0.9) 
 
18 (52.9) 
16 (47.1) 
0 
 
79 (54.5) 
65 (44.8) 
1 (0.7) 
Family history of arthritis 
    Yes (%) 
 
23 (42.6)* 
 
52 (46.8)* 
 
11 (33.3)* 
 
63 (43.4)† 
History of knee injury 
     Yes (%) 
 
3 (5.5) 
 
77 (69.4)‡ 
 
23 (71.9)† 
 
100 (69.0)§ 
History of knee pain 
     Yes (%) 
 
2 (3.6) 
 
51 (45.9) 
 
32 (100)† 
 
83 (57.2)║ 
Kellgren and Lawrence Grade, 
Number of knees with 
Grade 0/1/2/3/4 
 
 
          -- 
 
 
-- 
 
 
0/10/20/11/4 
 
 
-- 
KOOS, range = 0-100 (worst to 
best state), median (IQR) 
Other symptoms  
Pain 
 
 
100 (7.1) 
100 (2.8) 
 
 
53.6 (19.6) 
80.6 (27.8) 
 
 
37.5 (29.5) 
48.6 (23.6) 
 
 
53.6 (21.4) 
72.2 (30.6) 
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ADL 
Sport & Recreation 
QOL 
100 (0) 
100 (0) 
100 (0) 
89.7 (23.2) 
75.0 (40.0) 
68.8 (31.3) 
58.8 (27.7) 
17.5 (39.1) 
15.6 (31.3) 
80.9 (29.4) 
58.0 (50.0) 
56.3 (43.8) 
Missing data * n=1, † n=3, ‡ n=4, § n=9, ║n=2. 
BMI, Body mass index 
KOOS, Knee injury and Osteoarthritis Outcome Score 
ADL, Activities of Daily Living 
QOL, Quality of Life 
IQR, Inter-quartile range 
Kellgren and Lawrence grade severity: 0 (normal) is no OA; 1 (doubtful) is possible joint space narrowing 
and osteophytes, 2 (minimal) is definite joint space narrowing and osteophyte, 3 (moderate) is definite joint 
space narrowing, multiple osteophytes, some sclerosis and possible bone contour deformity, 4 (severe) is 
marked joint space narrowing, large osteophytes, severe sclerosis and definite bone contour deformity.20  
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        Table 3.2 Results from factor analysis using Horn’s parallel analysis 
 
 
 
 
 
 
 
 
 
 
Factor Empirical Eigenvalue 
(95% CI) 
Randomly Generated 
Eigenvalue 
Percent Variance 
Explained  based on 
empirically generated 
eigenvalue 
1* 5.97 (5.02, 6.92) 1.67 45.9 
2 1.35 (1.13, 1.57) 1.49 10.4 
3 1.22 (1.03, 1.41) 1.36 9.3 
4 1.12 (0.94, 1.30) 1.26 8.6 
5 0.69 (0.58, 0.80) 1.18 5.2 
*Only factor suitable for extraction from the QuIKS. 
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3.4.3 Data fit to the Rasch model 
Rasch analysis used the partial credit model. The main results of the Rasch analysis are 
summarized in Table 3.3. Initially, the QuIKS did not fit the Rasch model. Therefore, its 
measurement properties were refined through eight rounds of Rasch analysis. One set of 
modifications or data manipulation was performed in each round of Rasch analysis, guided 
by information obtained in the preceding rounds. 
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Table 3.3 Summary fit statistics from Rasch analysis 
Version Data changes Sample 
size 
Item-trait interaction  χ2 Item fit residual Person fit residual 
PSI 
Significant 
t-tests, % Value (df) P value Mean SD Mean SD 
Initial None 145 73.512 (13)* 0.000 0.49 1.84 -0.22 1.18 0.89 7.0 
Run 2 Deleted 8 misfit persons 137 72.550 (13) 0.000 0.43 1.93 -0.14 1.01 0.90 5.2 
Run 3 Rescored all items 137 19.693 (13) 0.103 -1.01 1.21 -0.66 1.29 0.89 1.6 
Run 4 † Deleted 20 misfit persons 117 16.105 (13) 0.243 -0.58 1.12 -0.41 1.08 0.90 4.8 
Run 5 Formed 4 testlets 117 0.937 (4) 0.92 0.26 0.72 -0.35 0.87 0.84 1.3 
Run 6 † Used initial data, 
rescored all items 145 19.480 (13) 0.108 -1.07 1.33 -0.70 1.33 0.89 4.3 
Run 7 Formed the 4 testlets 
again 145 3.546 (4) 0.47 0.02 0.85 -0.45 0.89 0.83 2.9 
Run 8 Deleted 1 misfit persons 144 3.612 (4) 0.46 0.03 0.85 -0.43 0.86 0.82 2.9 
Rasch-
Refined 
Deleted 3  persons 
with incomplete data         141 3.613 (4) 0.46 0.00 0.87 -0.44 0.86 0.82 3.0 
*
 Significant after P < 0.05 with Bonferroni correction for the number of items in the analysis. † Had local item dependency. Criteria of fit to Rasch 
Model: minimum sample size of n = 108, PSI (Person Separation Index) ≥ 0.80 for reliability assessment by measurement scale,  P-value of χ2 > 
0.05[Bonferroni-adjusted], Items- and Persons- Fit Residual Mean ~ 0 and SD (Standard Deviation) ~ 1, less than 5% significant t-test.  
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Eight items had disordered thresholds. There was equitable utilization of response 
categories across most items. The exceptions were items of the medications subscale, for 
which the subjects predominantly endorsed the ‘None – 0’ category. Rescoring the 
category response structure of all 13 items from five-level to three-level numeric response 
categories resolved all threshold disorders. In this new category response structure, the 
middle three response options have the same value (e.g. 0-1-2-3-4 became 0-1-1-1-2), thus 
assigning an equal score for the three inner response categories. As an example, figure 3.1 
depicts the category probability curves of one item of the modifying subscale before and 
after being rescored. There was no DIF.  
The residual correlation matrix of the items indicated that the four subscales had local item 
dependency, which grouped the items into their respective subscales. Only one pair of 
items of the interpreting subscale had residual correlations >0.2, but its items were still 
considered a subscale because their residuals were most correlated with each other.  The 
results from Horn’s parallel analysis, coupled with these results, suggested that the 
dominant construct in the QuIKS is a higher-order factor, while its subscales are lower-
order factors. Existing theory, prior research and the preceding results in this study guided 
our decision to form four testlets corresponding to the original four subscales. There was a 
large proportion of common variance (A = 0.93) among the testlets, which indicated that a 
single dominant construct (i.e., illness perception and behaviour) was captured by the 
QuIKS. Finally, data for four subjects were removed; one subject with an individual data 
pattern that misfitted the Rasch model and three subjects who each had data missing for 
one item.   
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Panel A: Before Rescored 
 
Panel B: After Rescored 
 
Figure 3.1 Category probability curves of one item from the modifying subscale - ‘I 
participate in certain activities less often to avoid aggravating my knees’ before formation 
of testlets. Panel A depicts disordered response category thresholds. Panel B depicts the 
item’s response scale after the three inner response categories were rescored to have an 
equal value of one, thus creating a logical and sequential ordering of its thresholds. 
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This refined QuIKS conformed to the expectations of summary fit to the Rasch model, as 
revealed by a non-significant item-trait interaction χ2, see Table 3.3. Only 3.0% of subjects 
had significant independent t-tests, confirming the unidimensionality of the illness 
perception and behaviour construct in the refined QuIKS. This Rasch-refined QuIKS had a 
PSI of 0.82, which is adequate to distinguish up to three distinct levels of illness perception 
and behaviour. Figure 3.2 depicts findings that suggested the Rasch-refined QuIKS was 
suitable for assessing the subjects, because the mean (SD) person estimate was 0.08 (1.19) 
with an item estimate mean of 0.00. The subscales of the Rasch-refined QuIKS had a 
hierarchical order from less to more illness perception and behaviour in logit scores as 
follows:  monitoring (-0.886), modifying (-0.192), interpreting (-0.112) and medication 
(1.19). There were no floor or ceiling effects.   The Appendix provides the Rasch-refined 
QuIKS. A table at the bottom of the Rasch-refined QuIKS (see Appendix A) provides the 
interval level scores (vary 0 to 100) that correspond to the total raw scores (vary 0 to 26).  
 
 
 
 
 
 
 
 
 
 
  
 
 96 
 
 
 
Figure 3.2 Fitting persons and items threshold distribution on the same logit scale. 
The distribution of the subjects’ estimate of illness perception and behaviour is in the upper 
histogram, with increasing illness perception and behaviour from left to right on the x-axis. 
 The distribution of the 13 items threshold estimate is the lower histogram, with higher 
illness perception and behaviour from left to right on the x-axis. 
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3.4.4 Factor structure of QuIKS 
Results from confirmatory factor analysis substantiated the results from the Horn’s parallel 
analysis and Rasch analysis. We tested the one-dominant construct (second-order factor) 
and four-testlet (first order factors) structure of the 13-item Rasch-refined QuIKS, and the 
data showed adequate fit to the model [CFI = 0.94, TLI = 0.92, and RMSEA = 0.08 (95% 
CI = 0.06-0.10]. Thus, the Rasch-refined QuIKS conformed to a unidimensional model. 
 
3.4.5 Known-groups validity 
The Kruskal-Wallis H test, where H is the test statistic, revealed that the total scores on the 
Rasch-refined QuIKS were significantly different among the three knee-health groups (H = 
123.01, df = 2, and P < 0.001), with a median (inter-quartile range) of 100.0 (12.7) for HK, 
52.9 (21.4) for KP, and 29.7 (13.8) for pre-HTO. There was a statistically significant 
moderate effect size between the HK and KP groups (n = 166) with Cohen’s d = 2.20 (95% 
CI = 1.81-2.60), z = -9.615, and P < 0.001, which indicated less illness perception and 
behaviour in the HK group compared to the KP group. There was a significant moderate 
effect size between the KP and pre-HTO groups (n =145) with Cohen’s d =1.32 (95% CI = 
0.99-1.66), z = -6.641, and P < 0.001. 
 
3.4.6 Convergent validity 
The QuIKS had a statistically significant moderate correlation (rs = 0.45-0.77) with each 
KOOS subscale. Its lowest correlation was with the KOOS-other symptoms (rs = 0.45), 
followed by the KOOS-sports and recreation function (rs = 0.65), the KOOS-activities of 
daily living (rs = 0.70), the KOOS-Pain (rs = 0.72), and its highest correlation was with the 
KOOS-quality of life (rs = 0.77).  
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3.5 Discussion 
Our findings affirmed all the hypotheses in this study. An updated version of the QuIKS, 
called the QuIKS-R, was adequately validated using information from Rasch analysis. The 
results suggest that the QuIKS-R encapsulates all four of its subscales into a 
unidimensional measure of illness perception and behaviour that captures the key 
experiences of knee pain symptoms that are consistent with knee OA. For clinicians and 
researchers, these findings mean that ratings on the QuIKS-R can be validly summed, 
much like marks on a ruler. First, calculate the total raw score, then use the conversion 
table at the bottom of the QuIKS-R (see Appendix A) to obtain the corresponding interval-
level (final) total score.  These interval-level scores represent an individual’s level of 
illness perception and behaviour. To the best of our knowledge, the QuIKS-R would be the 
first unidimensional measure designed to quantify illness perception and behaviour 
specifically for people with early symptoms of symptomatic knee OA.10, 11 
It made conceptual sense to condense the three middle response categories of each item, 
given the descriptors used for these categories. In the medication subscale we combined 
‘Rarely’, ‘Sometimes’, and ‘Often’. We did this because it might have been difficult for 
subjects to recall their illness response and then choose a response category that best 
classified their experience. It is possible that the subjects did not use a consistent pattern 
when selecting between ‘Rarely’ and ‘Sometimes’ and between ‘Sometimes’ and ‘Often’. 
Perhaps more clearly defined descriptors, for example, ‘Rarely = 1 to 3 times per week’, 
‘Sometimes = 4 to 6 times per week’, and ‘Often = 7 to 9 times per week’ would remove 
ambiguity from among these categories.47 Furthermore, the other 10 items used five-point 
Likert scales with a ‘Neutral’ midpoint. The rescoring of these items could be explained in 
the context of the long history of debate on the implication of midpoints in rating scales.48 
A midpoint, such as ‘Neutral’, is sometimes misinterpreted or selected in a biased way.48 
However, its removal might push some respondents to choose adjacent categories,  
reducing the reliability and validity of the measure.48 Therefore, scoring the midpoint in the 
same manner as its adjacent categories was deemed a good solution for these two issues. 
This study suggests that the level of illness perception and behaviour increased as 
individuals moved from the monitoring, to the modifying, then the interpreting, and finally 
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to the medication subscale. This pattern means that subjects tended to indicate higher 
ratings on the monitoring subscale compared to the medication subscale. This pattern fits 
with the model of illness behaviour, the latter being a representation of the decision-making 
process during an illness.21 This model employs nine stages, starting from illness 
recognition and labeling to the application of treatment with consequential re-evaluation of 
the illness state by the individual, in an iterative process.21 Furthermore, the model of 
selective optimization with compensation 23 also offers a theoretical basis for some of the 
items in the QuIKS-R, as it provides an explanation of the process of adaptation in people 
with knee pain problems. For example, in the early stages of symptomatic knee OA, one 
would expect that a person might make the decision to stop engaging in a favorite activity 
because of their knee pain (selection), change their exercise routine because of the knee 
problem (compensation), and take medication before engaging in an activity to prevent 
pain (optimization).23, 49 For clinicians these findings mean that scores on the QuIKS-R 
capture on a continuum illness perception and behaviour of people with knee pain 
symptoms that are consistent with knee OA. 
Forming testlets to obtain unidimensionality demonstrated that the subscales of the QuIKS 
are sub-constructs of illness perception and behaviour. When measuring a construct, 
measures with fewer items tend to have higher accuracy but lower precision.18, 19 By 
forming the testlets, we were able to capitalize on the accuracy of the subscales while also 
capitalizing on the precision of the full questionnaire, thereby providing more information 
about an individual’s level of illness perception and behavior in a single score.  It is worth 
noting that the individual testlets should not be used for score interpretation. Only the total 
scores from all 13 items of the QuIKS-R should be interpreted, and this interpretation 
should be in the context of the higher-order construct of illness perception and behaviour.  
The QuIKS-R discriminated between the study groups. The pre-HTO group had the highest 
level of illness perception and behaviour, followed by the KP, then the HK group, with a 
significant between-group difference of at least a moderate effect size. There are no 
previous studies of the QuIKS with which to compare these findings. However, population-
based reference data of each subscale of the KOOS supports the values obtained in the 
present study.50, 51 For example, the KOOS-pain median score for the KP and pre-HTO 
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groups were 80.6 and 48.6 respectively, and 97.2 for people aged 35 to 54 years in a 
population-based group.50 This is logical given that the prevalence of symptomatic knee 
OA increases with age and OA-related knee pain usually becomes more severe over time.3, 
52
 A lower correlation between the QuIKS-R and the KOOS-other symptom subscale, when 
compared to the QuIKS-R’s correlation with the other KOOS subscales, could mean that 
the level of illness perception and behaviour in the study population was less related to 
other joint impairments but highly related to activity limitations and knee-related quality of 
life. For clinicians, these findings mean that the QuIKS-R may be useful in discouraging 
physical activity limitations and helpful in promoting or maintaining quality of life in 
patients with knee pain symptoms consistent with knee OA.   
One of the main advantages of the QuIKS-R over the original 13-item QuIKS is the 
unidimensionality it gained after the ambiguity was removed from the rating scale of each 
item. This finding suggests that the QuIKS-R has an improved ability to discriminate 
compared to its predecessor.  Also, along with its validity specifically for people with OA-
like knee pain, a main advantage of the QuIKS-R over other measures of illness perception 
and behaviour is its proposed ‘unified construct of illness perception and behaviour’. 
 
3.6 Limitations and future research 
A limitation of this study was that the subjects in the KP group did not receive a medical 
diagnosis, so their knee pathology could be unrelated to knee OA. Also, while known-
group (discriminative) validation supported the QuIKS-R ability to discriminate the level 
of illness perception and behaviour between the healthy group and two severely involved 
groups, this information might not be useful for a clinician’s assessment of individual 
patients. Future studies should use a larger sample and evaluate the predictive validity of 
the QuIKS-R in identifying subjects with OA-like knee pain who are at greatest risk for 
physical activity limitations. 
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3.7 Conclusions 
The QuIKS-R is a unidimensional measurement scale that provides an interval-level score 
of illness perception and behaviour in persons with knee pain symptoms consistent with 
symptomatic knee OA. Scores on the QuIKS-R that represent more illness perception and 
behaviour, also mean that a patient is more aware of and affected by their knee pain, and 
has tried more to remedy their condition. This information might be useful for clinicians in 
guiding pain management interventions by identifying important issues to address in the 
therapy of people experiencing early symptoms of symptomatic knee OA. 
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Chapter 4 
4 Behavioural measures in a rat model of post-traumatic 
knee OA 
This chapter was reprinted with permission. A version of this chapter has been published 
as: 
Hamilton CB, Pest  MA, Pitelka V, Ratneswaran A, Beier F, Chesworth BM. Weight-
bearing asymmetry and vertical activity differences in a rat model of post-traumatic knee 
osteoarthritis. Osteoarthritis and Cartilage. In press (2015). 
doi:10.1016/j.joca.2015.03.001. 
4.1 Abstract 
Objective: This study used a rat model of post-traumatic knee OA created by anterior 
cruciate ligament transection with partial medial meniscectomy (ACLT + pMMx). In this 
model, mild to moderate structural changes that are typical of knee OA have been observed 
within two and eight weeks post-surgery.  The aim was to determine whether pain-related 
behaviours can distinguish between an ACLT + pMMx and a sham surgery group. 
Design: Three-month old male Sprague-Dawley rats underwent ACLT + pMMx on their 
right hindlimb within two groups of n = 6 each, and sham surgery within two groups of n = 
5 each. Assessments evaluated percent ipsilateral weight-bearing for static weight-bearing 
and 18 different variables of exploratory motor behaviour at multiple time points between 
one and eight weeks post-surgery. Histology was performed on the right hindlimbs at four 
and eight weeks post-surgery.  
Results: Histology confirmed mild to moderate knee OA changes in the ACLT + pMMx 
group and the absence of knee OA changes in the sham group. Compared to the sham 
group, the ACLT + pMMx group had significantly lower percent ipsilateral weight-bearing 
from one through eight weeks post-surgery. Compared to the sham group, the ACLT + 
pMMx group had significantly lower vertical activity (episode count, time, and count) 
values.   
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Conclusions: These findings suggest that ipsilateral weight-bearing deficit and vertical 
activity limitations resulted from the presence of knee OA-like changes in this model. 
When using the ACLT + pMMx-induced rat model of knee OA, percent ipsilateral weight-
bearing and vertical activity distinguished between rats with and without knee OA changes. 
These variables may be useful outcome measures in preclinical research performed with 
this experimental post-traumatic knee OA model. 
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4.2 Introduction 
The clinical presentation of knee OA typically involves chronic pain and physical 
disability.1 Pain does not always accompany knee OA, but symptomatic knee OA is very 
prevalent.2, 3 For example, the lifetime risk of developing symptomatic knee OA in the US 
has been estimated to vary between 9.6% and 23.9%, depending on a person’s age, sex, and 
obesity status.3 In humans, the presence of OA pain is associated with negative outcomes 
such as activity limitations, participation restrictions, and reduced quality of life1. These 
symptoms may be observed as behavioural changes, beginning at the early stages of the 
disease before diagnosis, and continuing through to its late stages.4-6 
Several rat models of OA serve as surrogates to the disease in humans, and are useful in 
preclinical studies on pharmacology and pathophysiology of the disease.7 Chemical 
(particularly, monosodium iodoacetate - MIA) and surgical induction methods are the two 
most commonly used to create experimental knee OA models with rats.7, 8 The surgical 
induction methods are particularly suited for studying post-traumatic knee OA. 
In humans, previous ligamentous knee joint injury, such as an ACL tear, is a major risk 
factor for knee OA.9 In most instances, an ACL tear is accompanied by a meniscal tear.10 
On average, 50% of individuals develop knee OA within 10 to 20 years after an ACL 
tear.10, 11  
We used a preclinical rat model of post-traumatic knee OA created by ACL transection 
with partial medial meniscectomy (ACLT + pMMx).12-15 The model acts by destabilizing 
the joint and disrupting its biomechanics, and thus has high clinical relevance in the study 
of knee OA.12 This model’s changes in joint structure and gene expression have been well 
characterized in previous studies.12-15 Histology and micro-computed tomography (µCT) of 
the knee joints have demonstrated the presence of changes that were characteristic of mild 
to moderate knee OA in the ACLT + pMMx rats between two and eight weeks post-
surgery.12 The structural changes have been determined to be similar to early stage knee 
OA in humans.12 In rat models of post-traumatic knee OA, some aspects of their pain-
related behaviours have been characterized, such as weight-bearing deficit and gait 
changes.7  However, static weight-bearing and exploratory motor behaviour (spontaneous 
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locomotor activities) have not been previously published for this particular model, to the 
best of our knowledge.  
The assessment of pain and physical function are vital components of the clinical 
assessment of patients with symptomatic knee OA.16 The assessment of pain-related 
behaviour is becoming more popular in rat models of OA because of its utility for 
increasing the translatability of animal studies to human clinical settings.7, 17 This increased 
popularity is made evident by the recent special issue from the journal Osteoarthritis and 
Cartilage on ‘Pain in Osteoarthritis’ and other recent publications.7, 8, 17 The special issue 
highlighted the use of pain-related behaviour assessments in rat models of knee OA.7, 8 
Most of this published work has been done with MIA induced rat models of OA that induce 
mechanical allodynia, which is common in painful non-injured sites in humans.8, 18 
Exploratory motor behaviour, as investigated in the present study, has not been previously 
published for any rat model of post-traumatic knee OA but has been used with other post-
surgery rodent models.17 Exploratory motor behaviour was recently characterized for a 
mouse model of post-traumatic knee OA by testing spontaneous locomotor activity in an 
open field tester.19 The investigators found no difference between the model and sham 
groups, which might be a consequence of the period of assessment or the variables of 
exploratory motor behaviour that were studied.19 Other studies using rat models of knee 
OA have observed certain characteristics of activity limitation such as reduced locomotion, 
rearing and climbing.7, 20, 21 Pain-related behaviour exhibited by a rat model of OA is 
dependent on the type rather than the extent of joint damage.7, 22 
Therefore, the aim of this study was to determine whether static weight-bearing and 
variables of exploratory motor behaviour in rats can be used to distinguish between an 
ACLT + pMMx-induced rat model of post-traumatic knee OA and a sham surgery control. 
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4.3 Methods 
4.3.1 Animals 
All experimental procedures were conducted in accordance with protocols approved by the 
University of Western Ontario Animal Care and Use Committee in agreement with federal 
regulations (Animal protocol No. 2007-045). Subjects were male Sprague-Dawley rats 
(Charles River Laboratories, St. Constant, Quebec, Canada) that arrived at 10 weeks old 
and weighed between 301g to 325g. The rats were caged doubly and then singly after 
surgery in a ventilated animal room with controlled temperature (20 oC to 25 oC) and 
controlled humidity (40% to 60%). They were placed on a 12 hour light/dark cycle starting 
at 7 am and received food and water ad libitum. 
 
4.3.2 Study design 
Figure 4.1 is a schematic of the experiment protocol. Rats were randomly allocated to the 
two main study groups, two alternate groups, and a naïve group (n = 5). The alternate 
ACLT + pMMx and sham groups were sacrificed at four weeks post-surgery, and the main 
study groups and the naïve group were sacrificed at eight weeks post-surgery by CO2 
asphyxiation. Hindlimbs were harvested, then fixed in 4% paraformaldehyde overnight, 
and decalcified for four days in Formical-2000 (Decal Chemical Corp.) for later 
histological assessment. The alternate groups were treated in the same manner as the main 
study groups, including behaviour assessments. 
 
 
 
 
 
 
  
 
 
Figure 4.1: Schematic of experimental protocol
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4.3.3 ACLT + pMMx-induced OA 
The ACLT + pMMx group (n = 6) had surgery to their right hindlimb to induce the model 
of post-traumatic knee OA using a well-established protocol previously described, without 
forced mobilization following surgery.12-15, 23 The sham group (n = 5) had surgery only to 
visualize the ACL and medial meniscus of the right hindlimb. Additionally, to emulate the 
experimental conditions of pre-clinical drug treatment trials, an osmotic minipump (Alzet 
2ML4) filled with sterile distilled water was surgically installed subcutaneously between 
the scapulae of each rat in both the ACLT + pMMx and sham groups.24 A similar surgery 
was performed four weeks later, to replace the now exhausted pumps with fresh 
units. During surgery all rats were anaesthetized via isoflurane inhalation. Analgesic 
buprenorphine (50µg/kg) was injected subcutaneously. This was done once pre-emptively 
during the surgery and once every 8 hours up to 48 hours following the surgery.  
 
4.3.4 Structural joint changes 
Animals from the main ACLT+pMMx group and sham group were sacrificed eight weeks 
post-surgery for histology assessments. The alternate groups were followed for four weeks 
post-surgery before their knee joints were harvested for histology to confirm the presence 
of early OA-related structural changes. Harvested limbs were processed and embedded in 
paraffin wax following fixation and decalcification. Serial frontal sections were cut 
spanning the loading portion of the ipsilateral (right) knee joint. Sections were stained from 
six different depths spanning approximately 1200µm of the joint, using 0.04% toludine 
blue.25 Structural joint changes were assessed by using the Osteoarthritis Research Society 
International (OARSI) guidelines for histomorphometry and pathology scoring by a 
blinded scorer (M.A.P.).26 This guideline is an ordinal grading system in which lower 
scores represent less cartilage degeneration.26 Grading was performed for three zones for 
each of medial tibial plateau (MTP) and the medial femoral condyle (MFC). For each, the 
grades have numeric values of 0, 1, 2, 3, 4, and 5 with the corresponding descriptors being 
none, minimal (5-10%), mild (11-25%), moderate (26-50%), marked (51-75%), and severe 
(more than 75%) respectively. The final cartilage degeneration score for the MTP and for 
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the MFC was calculated by summing the scores from the three zones of each respective 
anatomic site.26  
 
4.3.5 Static weight-bearing 
Static weight-bearing was a construct of weight-bearing deficit between the ipsilateral 
(right) and contralateral hindlimbs when a rat was stationary.7, 22 This was assessed during 
the 12 hour light phase at one, two, four, six, and eight weeks post-surgery using an 
Incapacitance Tester (Linton Instrumentation, Norfolk, UK) shown in Figure 4.2, with the 
exception of the six weeks’ time point for the naïve group. During the assessment 
procedure, each rat was habituated to a relatively static position in a conventional restrainer 
and separate transducers recorded the average weight on each hindlimb over five seconds 
for five trials. Changes in the hind paw weight-bearing distribution between the left 
(contralateral control) and right (ipsilateral) hindlimbs were utilized as an index of joint 
pain-like symptoms in the knees that had surgery to induce the model of knee OA. 
Therefore, as a likely indicator of OA pain, percent ipsilateral weight-bearing was 
subsequently calculated as weight on the ipsilateral hindlimb divided by weight on both 
hindlimbs multiplied by 100 as per.27 The average percent ipsilateral weight-bearing per rat 
at each time point was used in the statistical analyses. 
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Figure 4.2: Incapacitance Tester. This instrument was used to assess static weight-
bearing.   
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4.3.6 General exploratory motor behaviour 
Exploratory motor behaviour is a common construct that has been used in numerous 
pharmacologic and non-pharmacologic studies including small animal research dating back 
to the 1950s.28, 29 It captures spontaneous locomotor activity within a given space and is 
related to self-motivation and curiosity.7, 17, 28 Exploratory motor behaviour was assessed 
during the dark phase in an unlit animal room using an open field tester (AccuScan 
Instruments, Omnitech Electronic, Columbus, OH) with a transparent Plexiglas cage  
(height = 33cm, width = 42cm, and length = 42cm), see Figure 4.3. The cage had three 
pairs of sensors. Each pair of sensors had 16 infrared light beams, equally spaced, that 
detected activity when broken. Two pairs of sensors captured activity in the horizontal 
plane at the base of the cage, and one pair captured vertical activity at 19 cm above the 
base of the cage.  Data were automatically uploaded into a computer using the 
accompanying software. During the assessment, the computer screen was covered to 
minimize exposing the rats to illumination. Exploratory motor behaviour assessment was 
started at four weeks post-surgery, after allowing sufficient time for early stage knee OA-
like structural joint changes to begin and post-surgery pain to dissipate. Each rat explored 
the open field for 30 minutes at four, six and eight weeks post-surgery. However, this 
assessment was done only at eight weeks post-surgery for the naïve group. Eighteen 
different variables of exploratory motor behaviour were captured, encompassing frequency 
counts and duration of horizontal, sedentary, stereotypic, revolution movement and vertical 
activities (see Table 4.1 for complete list). Disturbance of the rats was avoided during the 
assessments to avoid influencing their movement. 
 
 
 
 
 
 
  
Figure 4.3: Open-field Tester. 
behaviour. 
 
 
 
 
 
 
 
 
 
 
 
This instrument was used to assess exploratory motor 
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Table 4.1: Repeated Measures ANOVA results for variables of exploratory motor 
behaviour 
Variable* 
Main Effects 
Interaction Effect Group 
F(1,8), P-Value 
Time 
F(2, 16), P-Value 
Ambulatory Activity Count  3.61, 0.09 2.06, 0.16 0.160, 0.85 
Ambulatory Activity Time  5.13x10-3, 0.99 4.93, 0.02 0.300, 0.74 
Ambulatory Episode Count 0.040, 0.85 12.1, <0.001 7.31, 0.006 
Horizontal Activity Count  3.55, 0.10 1.99, 0.17 0.135, 0.103 
Locomotor Clockwise Revolutions 1.67, 0.219 3.58, 0.05 3.38, 0.05 
Locomotor Counter-Clockwise 
Revolutions 
0.300, 0.60 6.45, 0.01 7.72, 0.004 
Movement Episode Count  0.389, 0.55 0.937, 0.41 0.767, 0.48 
Movement Time  2.66, 0.14 0.731, 0.50 0.102, 0.90 
Rest Episode Count  0.419, 0.54 0.922, 0.42 0.713, 0.51 
Rest Time  2.67, 0.14 0.725, 0.50 0.103, 0.90 
Total Distance  0.336, 0.578 6.07,0.01 0.740, 0.49 
Stereotypic Activity Count 0.021, 0.89 2.06, 0.16 0.231, 0.80 
Stereotypic Episode Count  0.027, 0.87 1.81, 0.20 0.227, 0.80 
Stereotypic Episode Activity Count 2.99, 0.12 1.18, 0.20 0.037, 0.96 
Stereotypy Time  0.457, 0.52 4.48, 0.03 0.014, 0.99 
Vertical Activity Count  14.2, 0.005 3.29, 0.06 0.445, 0.65 
Vertical Activity Time  16.4, 0.004 10.1, 0.002 0.874, 0.44 
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Vertical Activity Episode Count 16.7, 0.004 7.53, 0.005 0.383, 0.69 
*
 Distance is in centimeters, time is in seconds, count and revolution are in numbers. 
Bolded P-values are significant at P < 0.05. 
Only the three vertical activity groups showed a statistically significant main effect between the rat groups, 
while seven variables had a statistically significant main effect by time, of which two had a significant 
interaction effect. 
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4.3.7 Statistical analysis 
Statistical analyses were conducted using the Statistical Package for the Social Sciences 
v.20 (SPSS Inc. Chicago, Illinois) and GraphPad Prism® v4 (San Diego, California). 
Graphs were constructed in GraphPad Prism® using means and their corresponding 95% 
confidence intervals (CI). 
Each dependent variable was a continuous variable, and had independence of observation 
at each time point in this study. The following tests of the underlying assumptions of the 
statistical analyses were performed and the data properties confirmed, unless otherwise 
stated below. Any outliers in the data, for each dependent variable within each group, were 
identified using the outlier labeling rule with the k coefficient = 2.2.30 Normality of the data 
distribution was assessed using the Shapiro-Wilk test of normality. Homogeneity of 
variance was assessed using Levene’s test for homogeneity of variance during the analysis 
of variance (ANOVA) and Student’s unpaired t-test. Sphericity was assessed using 
Mauchly’s test of sphericity during two-way repeated measures ANOVA. Differences 
between groups were based on statistical significance. In all analyses, statistical 
significance was tested with a two-tailed P < 0.05 with adjustment for multiple 
comparisons where applicable, such as Tukey’s post hoc test after one-way ANOVA and 
Bonferroni’s multiple comparison test that had one family with a family-wise alpha of 0.05 
for each variable tested at each time point. 
 
4.3.8 Analysis of static weight-bearing 
We hypothesized that, from one through eight weeks post-surgery, percent ipsilateral 
weight-bearing would have significantly lower values for the ACLT + pMMx group 
compared to the sham group. This hypothesis was tested using two-way repeated measures 
ANOVA, with post-surgery time point and rat group as the two independent variables, and 
percent ipsilateral weight-bearing as the dependent variable. This was followed by 
Student’s unpaired t-test of the main effects by rat group, one-way ANOVA with Tukey’s 
post-hoc testing of main effects by post-surgery time, and univariate parsing of interaction 
effects to evaluate static weight-bearing between and within the ACLT + pMMx and sham 
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groups across the time points. If a significant difference was found between the rat groups 
in the preceding analysis, Bonferroni’s multiple comparison test in GraphPad Prism® was 
used to evaluate whether percent ipsilateral weight-bearing values in the ACLT + pMMx 
and sham groups were significantly different from the values in the naïve group at four and 
eight weeks post-surgery. 
 
4.3.9 Analysis of exploratory motor behaviour 
For each of the 18 exploratory motor behaviour variables, we hypothesized that at four and 
eight weeks post-surgery, their values would have a statistically significant difference 
between and within the ACLT + pMMx and sham groups. Each hypothesis was tested 
using two-way repeated measures ANOVA as described for static weight-bearing. Each 
exploratory motor behaviour variable was a dependent variable. If the values of a variable 
were significantly different between the ACLT + pMMx and sham groups, Bonferroni’s 
multiple comparison test in GraphPad Prism®, evaluated whether their values in the ACLT 
+ pMMx and sham groups were significantly different from values in the naïve group at 
eight weeks post-surgery. 
Any dependent variable that had a significant difference between the ACLT + pMMx and 
sham groups was subsequently evaluated for association with OARSI cartilage 
degeneration scores at four and eight weeks post-surgery using Spearman’s correlation 
coefficient (rs). Values range from 0 to ±1, with rs  = -1 or 1 representing stronger 
correlations. 
 
4.4 Results 
4.4.1 Animal characteristics 
At surgery, the rats were about three months old with a mean (95% CI) weight of 409 (393-
426)g, 401 (386-415)g, and 390 (371-409)g for the ACLT + pMMx, sham, and naïve 
groups respectively. There was no significant difference between the rat groups at surgery, 
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or at four weeks and eight weeks post-surgery. Data of one rat from the ACLT + pMMx 
group was removed due to significant upper outlier values on the three vertical activity 
variables. Therefore, each group had 5 rats. Data from each dependent variable were 
approximately normally distributed at each time point. 
 
4.4.2 Structural changes of the joint 
Evidence of cartilage degeneration (red arrowheads, [Figure 4.4(A)]) and osteophyte 
development (yellow asterisks, [Figure 4.4(A)]) that were indicative of knee OA-like 
changes, was found in the medial compartment of ipsilateral knee joints of the ACLT + 
pMMx animals but not in the sham animals at four and eight weeks post-surgery. The 
OARSI scores of cartilage degeneration showed a significant difference (P < 0.005, Mann-
Whitney test) between the ACLT + pMMx and sham groups in both the medial tibial 
plateau (MTP) and medial femoral condyle (MFC). These groups’ respective mean scores 
of MTP degeneration at four weeks post-surgery were 4.2 (2.9-5.5) and 0.07 (-0.12-0.25) 
and at eight weeks post-surgery were 6.0 (3.8-8.2) and 0.27 (0.15-0.38).  These groups’ 
respective mean scores of MFC degeneration at four weeks post-surgery were 3.4 (2.3-4.5) 
and 0.10 (-0.09- 0.29) and at eight weeks post-surgery were 5.8 (3.1-8.6) and 0.07 (-0.05- 
0.18) [Figure 4.4(B) and Figure 4.4(C)]. Minor cartilage degeneration was observed in the 
lateral compartments of the ACLT + pMMx operated animals with significant differences 
compared to the sham animals [Supplementary data, Figure 4.5 (A, B)]. Evidence of minor 
fibrosis was identified in the medial but not the lateral synovium of the ACLT + pMMx 
animals [Supplementary data, Figure 4.5(C)]. 
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Figure 4.4: Evidence of OA in ACLT + pMMx operated rats as shown by histology 
(A) Representative toluidine blue stained sections of knee joints demonstrates histological changes congruent with early to mid OA in 
ACLT + pMMx (n = 6) but not sham operated animals (n = 5). Cartilage degeneration (red arrowheads) and osteophyte development 
(yellow asterisks) are indicated. (B) At 4 and (C) 8 weeks post-surgery, ACLT + pMMx rats showed significantly higher OARSI 
cartilage degeneration scores in the MTP and MFC of operated knee joints. **P < 0.005, Mann–Whitney statistical test. The values are 
presented as mean with 95% CI for each study group. T = medial tibia, F = medial femur. 
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4.4.3 The ACLT + pMMx animals demonstrated less ipsilateral 
static weight-bearing 
Development of pain-like symptoms following ACLT + pMMx was supported by the static 
weight-bearing analysis (Figure 4.5). The ACLT + pMMx group had significantly lower 
percent ipsilateral weight-bearing when compared to the sham group. During the two-way 
ANOVA, sphericity was assumed (Mauchly’s W = 0.257, P = 0.478), but the Greenhouse-
Geisser’s F values were used. Percent ipsilateral weight-bearing showed a significant 
interaction effect between post-surgery time and rat group (F(2.95, 23.61) = 5.59, P = 
0.005), and a significant main effect by rat group (F(1, 8) = 161.26, P < 0.001) and by time 
(F(2.95, 23.61) = 13.1, P < 0.001). Student’s unpaired t-tests with normality and equal 
variance assumed, showed that the ACLT + pMMx group had significantly lower percent 
ipsilateral weight-bearing at each post-surgery time point when compared to the sham 
control (Figure 4.5). One-way ANOVA with Tukey’s post-hoc testing showed that percent 
ipsilateral weight-bearing in the ACLT + pMMx group was significantly lower for week 
one compared to the other follow-up weeks (F(2.74, 10.96) = 7.60, P = 0.006), but not 
among the other weeks (P > 0.05). Whereas, in the sham group, percent ipsilateral weight-
bearing was significantly higher at six weeks post-surgery compared to one week and four 
weeks post-surgery (F(2.56, 10.24) = 10.7, P = 0.002).  However, the percent ipsilateral 
weight-bearing of the sham group was always equal to or greater than 50%.  
Bonferroni’s multiple comparison test demonstrated that the mean percent ipsilateral 
weight-bearing of the naïve group was not significantly different from the ACLT + pMMx 
group at four weeks (t = 2.75, adjusted P = 0.103), but was significantly higher than the 
ACLT + pMMx group at eight weeks post-surgery (t = 3.06, adjusted P = 0.020). Also, the 
mean percent ipsilateral weight-bearing of the naïve group was not significantly different 
from the sham group at both four weeks (t =0.658, adjusted P = 1.00) and eight weeks 
post-surgery (t = 0.059, adjusted P = 1.00). 
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Figure 4.5: Percent ipsilateral weight-bearing between rat groups. Percent ipsilateral 
weight-bearing assessed static weight-bearing as a likely indicator of pain. Percent 
ipsilateral weight-bearing was consistently statistically significantly lower for the 
ACLT/pMMx rats when compared to the sham operated rats. *At each time point, the 
groups had statistically significant difference at adjusted P < 0.001. The values are 
presented as means with 95% CI for each study group at each assessed post-surgery time 
point. 
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4.4.4 ACLT+pMMx animals performed less rearing in exploratory 
motor behaviour testing 
Of the 18 variables of exploratory motor behaviour investigated, a significant difference 
between the rat groups was only observed for the three variables that captured vertical (or 
rearing) activity. Seven variables had a significant main effect by post-surgery time, and 
two variables had a significant interaction effect (Table 4.1). For group effects, Student’s 
unpaired t-tests showed that the ACLT + pMMx group had significantly lower vertical 
activity (episode count,  time in seconds, and count) values at each of the assessment time 
points (Figure 4.4, Table 4.2). Only the sham group had a significant difference between 
time points, as observed where stereotypic activity time was different between week six 
and eight. Furthermore, for the sham group, six out of the other seven variables (the 
exception being total distance) had a significant difference between four weeks and eight 
weeks post-surgery (Table 4.2). Parsing of the two interaction effects revealed no 
additional significant difference between the groups at each time point.  
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Figure 4.6: Vertical episode count differed between rat groups. Vertical episode count 
was one of eighteen variables used to assess dynamic pain-related behaviour. It is one of 
the three vertical activity variable that consistently showed statistically significantly lower 
values for the ACLT + pMMx rats when compared to the sham operated rats from 4 
through 8 weeks post-surgery. *At each time point, the groups had statistically significant 
difference at adjusted P < 0.05. The values are presented as means with 95% CI for each 
study group at each assessed post-surgery time point. 
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Table 4.2: Repeated Measures ANOVA post-hoc testing results for exploratory motor 
behaviour 
Variable* 
Post-surgery time,  Sham and ACLT+pMMx group  
mean difference (95 % CI)  
Week 4 Week 6 Week  8 
Ambulatory Activity Count 1479 (-982 to 3940) 1177 (-1284 to 3639)  1732 (-729 to 4194) 
Ambulatory Activity Time† 4 (-47 to 55) -6 (-57 to 44) 3 (-48 to 53) 
Ambulatory Episode Count† -9 (-22 to 4) 0 (-14 to 13) 6 (-7 to 20) 
Horizontal Activity Count 1462 (-1036 to 3961) 1190 (-1309 to 3689) 1718 (-780 to 4217) 
Locomotor Clockwise 
Revolutions 
3 (-20 to 25) -12 (-35 to 11) 7 (-16 to 30) 
Locomotor Counter-
Clockwise Revolutions† 
14 (-4 to 32) 1(-18 to 19) -4(-22 to 15) 
Movement Episode Count -16 (-61 to 29) -15 (-59 to 30) 5 (-40 to 49) 
Movement Time 72 (-94 to 238) 60 (-106 to 226) 94 (-260 to 71) 
Rest Episode Count -16 (-61 to 29) -15 (-59 to 30) 5 (-40 to 49) 
Rest Time -72 (-238 to 94) -60 (-226 to 106) -95 (-261 to 71) 
Total Distance 983 (-1996 to 3963) 17 (-2963 to 2996) 823 (-2157 to 3803) 
Stereotypic Activity Count -17 (-147 to 113) 13 (-117 to 143) -14 (-144 to 116) 
Stereotypic Episode Activity 
Count 
1029 (-956 to 3014) 1224 (-761 to 3209) 1097 (-888 to 3082) 
Stereotypic Episode Count -3 (-50 to 45) 7 (-41 to 55) 4 (-44 to 52) 
Stereotypy Time‡ -5 (-29 to 19) -5 (-28 to 19) -6 (-30 to -18) 
Vertical Activity Count† 449 (156 to 747) § 439 (146 to 732) § 341 (49 to 633) § 
Vertical Activity Time† 143 (42 to 244) § 121 (20 to 222) § 109 (8 to 210) § 
Vertical Episode Count† 66 (24 to 109) § 55 (13 to 98) § 57 (14 to 100) § 
*
 Distance is in centimeters, time is in seconds, count and revolution are in numbers. 
†
 Statistically significant difference between week 4 and week 8 for the sham operated rats. 
‡
 Statistically significant difference between week 6 and week 8 for the sham operated rats. 
§
 Bonferroni’s multiple comparison test showed statistical significance between group differences at adjusted P < 
0.05. 
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Bonferroni’s multiple comparison test showed that at eight weeks post-surgery, compared 
to the naïve group, the ACLT+pMMx group had a significantly lower vertical activity 
episode count (t = 2.85, adjusted P = 0.029) and vertical activity count (t = 0.015, adjusted 
P = 0.019), but similar vertical activity time (t = 2.164, adjusted P = 0.103). Whereas, 
Bonferroni’s multiple comparison test showed that at eight weeks post-surgery compared 
to the naïve group, the sham group had a similar vertical activity episode count (t = 0.757, 
adjusted P = 0.927), vertical activity count (t = 0.757, adjusted P = 0.927), and vertical 
activity time (t = 0.267, adjusted P = 1.00). 
The OARSI cartilage degeneration scores for MTP and MFC association with percent 
ipsilateral weight-bearing and the variables of vertical activity were investigated. At eight 
weeks post-surgery, moderate to strong correlations were observed, which were in most 
cases statistically significant for MTP and for MFC with percent ipsilateral weight-bearing 
(rs = -0.71 , P = 0.022; rs = -0.65, P = 0.040), vertical activity episode count (rs = -0.71, P = 
0.020; rs = -0.83 , P = 0.003), vertical activity time (rs = -0.70, P = 0.024; rs = -0.54, P = 
0.105), and vertical activity count (rs = -0.59, P = 0.072; rs = -0.68, P = 0.030). The 
correlations at four weeks post-surgery were similar. The negative rs values indicated lower 
OARSI scores were correlated with higher percentage ipsilateral weight-bearing and higher 
vertical activity values. 
 
4.5 Discussion 
Our findings demonstrated that percentage ipsilateral weight-bearing and vertical (rearing) 
activity, based on statistical significance, differed between the ACLT + pMMx induced 
model of post-traumatic knee OA and sham surgery rats. Our data show that these two 
behaviours were moderately to strongly associated with the presence of mild to moderate 
osteoarthritic structural joint changes.12 Thus, the above findings provide evidence that 
these behaviours are consistent with symptoms of post-traumatic knee OA, and may be 
adequate for use to distinguish between rats with and without knee OA-like changes when 
using the ACLT + pMMx rat model.  
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It is common among research studies to find significant ipsilateral weight-bearing deficits 
in a knee OA rat model group when it is compared to a control group.7, 31-33 Most studies of 
rat models of post-traumatic knee OA have assessed weight-bearing during the gait cycle 
of rats,31-33 and therefore, would not measure static weight-bearing. Most other studies that 
did assess static weight-bearing and demonstrated a statistically significant weight bearing 
deficit on the ipsilateral hindlimb used MIA-induced OA rat models.7, 22 Studies that have 
assessed static weight-bearing for experimental models of post-traumatic knee OA either 
found no significant weight-bearing deficit22 or showed a significant difference while using 
short follow-up periods34 of usually up to four weeks post-surgery. Such short periods 
would only capture the very beginning stages of knee OA-like changes in the ACLT + 
pMMx rat model.12 
As far as we know, this is the first study to report on exploratory motor behaviour using the 
open field tester to assess rats with experimentally induced post-traumatic knee OA-like 
changes. The findings indicated that vertical (rearing) activity in the context of spontaneous 
locomotor activity may be useful in distinguishing between rats with and without ACLT + 
pMMx-induced knee OA-like changes. Findings of previous studies are conflicted on the 
utility of vertical activity in distinguishing between a post-traumatic model of knee OA and 
control groups in mice. One study found a significant difference in rearing activity between 
mice in a naïve group and a surgically destabilized medial meniscus induced model of knee 
OA at 16 weeks post-surgery.35 However, that study’s behavioural assessment was very 
lengthy, as it lasted 15 hours and used the Laboratory Animal Behavior Observation 
Registration and Analysis System (LABORAS) which utilizes vibration and force signals 
to detect exploratory motor behaviour.35 On the other hand, a 30 minute assessment in an 
open field tester found no significant difference in rearing time up to 12 weeks post-surgery 
between a bilateral cruciate ligament injury mouse model and a sham surgery group.19  
Thus, the present study may be the first to provide support for vertical activity as a measure 
to distinguish between rats of a post-traumatic model of knee OA and control groups. 
Vertical activity may be likened to sit-to-stand activity in humans, which is a valuable 
performance-based clinical measure of physical function in people with knee OA.36 
Compared to age and gender-matched controls, humans with early stage medial knee OA 
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have been reported to put less weight on their affected side when transitioning from a 
sitting to a standing position.37 Interestingly, these individuals with knee OA reported no 
pain at the time of assessment, but had previously been symptomatic.37 Therefore, a 
weight-bearing deficit could be related not only to pain but also to limb strength.38  
However, another study in humans showed that knee OA-related pain is moderately 
correlated with the time taken to perform the sit-to-stand activity.39 Thus, knee OA-related 
pain may be associated with a decrease in the number of vertical activity episodes 
performed within a given period of time. 
Using sham surgery as a control allowed for most of the difference between the groups to 
be attributable to the ACLT + pMMx surgery, and consequently to knee OA changes. The 
naïve control, further substantiated the strength of our results, by showing a statistically 
significant difference with the ACLT + pMMx group, but not with the sham control. 
Assessment of exploratory motor behaviour began at four weeks post-surgery, after 
allowing post-surgical pain to dissipate and for early stage knee OA-like changes to be 
established12. Furthermore, in the present study, the sham group did not develop OA-like 
structural changes compared to the development of OA-like changes in older middle-aged 
(12 months old) sham-operated rats in a previous study.40  
There were some limitations to this study. First, the ACL of the ACLT + pMMx rats were 
not reconstructed. Therefore interpreting whether the behavioural changes were 
independent of joint instability and attributable only to symptomatic knee OA-like changes 
is difficult.7 Second, values for some of the behavioural variables had high within-group 
variation. Thus, some statistical analyses may have been too underpowered to detect a 
statistically significant difference between the study groups for variables of exploratory 
motor behaviour other than the three vertical activity variables. In a future study, this 
limitation might be investigated by using larger group sizes and a longer duration for 
exploratory motor behaviour assessment. Also, another indication that a future study may 
benefit from a larger sample size was evident in the results of the static weight-bearing 
assessment where the naïve group’s ipsilateral weight bearing was higher than the ACLT + 
pMMx group at week 4 and week 8 post-surgery, but the difference was not statistically 
significant at week 4 post-surgery (i.e., adjusted P = 0.103). While, the naïve group had 
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almost identical scores to the sham group at both week 4 and week 8 post-surgery, as is 
made clear by the adjusted P-value of 1.0. Third, a drug delivery pump was installed, 
which makes our findings limited to conditions under which a similar approach is used for 
drug delivery. Efforts were taken to reduce the trauma involved in pump installation. 
However, it is possible that these surgeries, and the short term analgesics which followed 
may influence long term pain pathways. Fourth, changes in exploratory motor behaviour 
could reflect pain but also other disturbances. Finally, the assessor of the behavioural 
outcomes was not blinded to group allocation, which might have allowed some observer 
bias when measuring differences in ipsilateral percent weight-bearing between study 
groups.41 Future studies could use a blinded assessor when performing these assessments. 
 
4.6 Conclusions 
This study demonstrated that percent ipsilateral weight-bearing and three vertical activity 
variables (i.e. vertical activity count, vertical activity time, and vertical activity episode 
count) are useful measures to distinguish rats with and without ACLT + pMMx-induced 
post-traumatic knee OA-like changes. Our data suggest that these behavioural assays can 
be added as valuable functional outcome measures in studies using rat models of OA; 
however, their relevance for translational studies of new experimental treatments needs to 
be further evaluated. 
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4.8 Supplementary data 
The following is the supplementary data related to this chapter: 
 
Figure 4.7: No evidence of OA found in the lateral knee joint compartments of ACLT 
+ pMMx operated rats 
(A) Representative toluidine blue stained sections of knee joints demonstrates healthy 
lateral compartment cartilage in anterior cruciate ligament transection and partial medial 
meniscectomized (ACLT + pMMx, n = 6) and sham operated animals (n = 5). (B) At 4 and 
 133 
 
(C) 8 weeks post-surgery, ACLT + pMMx rats showed very minor but statistically 
significantly higher OARSI cartilage degeneration scores in the lateral tibial plateau (LTP) 
and lateral femoral condyle (LFC) of operated knee joints. (D) Representative toluidine 
blue stained sections of the medial knee joint synovium shows minor fibrosis in 
ACLT + pMMX rats. (E) Representative toluidine blue stained sections of the lateral knee 
joint synovium shows comparable histology between ACLT + pMMX and sham operated 
rats. *P < 0.05, **P < 0.005, Mann–Whitney statistical test. The values are presented as 
mean with 95% CI for each study group. T = lateral tibia, F = lateral femur.
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Chapter 5 
5 General Discussion 
In recent years, several studies have been published that investigated the identification, 
treatment and lived experiences of symptomatic knee OA to gain a better understanding of 
how to prevent or reduce its ill-effects and progression.1-4 These ill-effects include 
increasing pain, physical activity limitations, physical dysfunction, psychological 
dysfunction, and loss of quality of life.5 At present, there seems to be no single solution; 
but the progress that has been made demonstrates the importance of a multifactorial 
approach to the identification/diagnosis and treatment of symptomatic knee OA.5, 6  
Three domains that can be used to characterize phenotypes of pain in knee OA have 
previously been identified.6 These three domains highlight distinct characteristics of 
symptomatic knee OA that can be used in identifying, providing prognoses and treating 
knee OA.6 These three domains are “knee pathology, psychological distress, and pain 
neurophysiology” as stated by Kittelson et al. (2013: p. 422).6 Of particular importance to 
the research presented in this thesis was the psychological distress domain, because of its 
consistency with the definition used for illness perception and behaviour in this thesis.6  
 
5.1 Measures of illness perception and behaviour 
Chapter two of this thesis showed that 16 validated measures of illness perception and 
behaviour have been previously used to assess people with knee pain/OA. These measures 
fit with Kittelson et al’s examples of measures of psychological distress—measures of fear-
avoidance beliefs, pain catastrophizing, self-efficacy, and coping.6 This means that the 
identified measures fit within the psychological distress domain used to define phenotypes 
of pain in knee OA. This supports the importance of the findings in chapter two, showing 
chapter two is a useful source of information that summarizes measures in the 
psychological distress domain that can be useful in therapy and research of people who 
have knee pain/OA. By using a novel strategy of applying four components derived from 
the definition used for illness perception and behaviour,11 my research was able to highlight 
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the measures’ comprehensiveness in operationalizing the concept in the 16 measures. Thus, 
chapter two is a useful resource for clinicians and researchers when they are selecting 
measures to assess illness perception and behaviour in people with knee pain/OA. 
However, users of these measures are recommended to delve deeper into research on the 
measurement properties of each measure before making their final decision to use any of 
the 16 measures.12    
In chapter two, the primary findings indicated that the QuIKS was the only validated 
measure that captures all four components of illness perception and behaviour in the target 
sample. This finding supports the QuIKS’s potential to be an important measure in 
identifying and providing prognoses for people with early symptoms of knee OA. The 
QuIKS could be used alongside measures of knee pain and knee pathology to describe the 
phenotype of knee pain in individuals with early symptoms of knee OA. The diverse ways 
in which the measures of illness perception and behaviour have been used to account for 
changes in pain, physical activity, physical function, psychological function, and quality of 
life for people with knee pain/OA speaks to the importance of pursuing future work on the 
measurement properties of the QuIKS. When the scoping review was conducted, only one 
study had been published about the measurement properties of the QuIKS, and the 
publication provided content validation and proof of internal consistency.8 Also, there was 
another study which provided construct validation for one of its four subscales.13 
Therefore, other measurement properties of the QuIKS needed to be evaluated before it can 
be used during the care of people with the early symptoms of knee OA.   
 
5.2 Interval-level measure of illness perception and 
behaviour 
In chapter three, construct validation was provided for the QuIKS beyond the published 
works identified in chapter two. More specifically, a Rasch-refined version of the QuIKS 
(QuIKS-R) was developed which has interval-level scaling of illness perception and 
behaviour in people with knee pain/OA. The interval-level scaling of illness perception and 
behaviour by the QuIKS-R is important because it allows for making interpretation on the 
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relative distance between scores. This kind of interpretation is not recommended when 
using nominal-level and ordinal-level scaling of measurement which are lower levels of 
measurements compared to interval-level measurement. Interestingly, none of the other 15 
validated measures of illness perception and behaviour included in the scoping review 
obtained validation using Rasch analysis. Based on the findings in chapter two and chapter 
three, the QuIKS-R is the first measure to demonstrate interval-level scaling for illness 
perception and behaviour among people with knee pain/OA. This is significant, as it puts 
the QuIKS-R at the forefront of measures with sound measurement properties that can be 
used to discriminate illness perception and behaviour among persons with knee pain/OA. 
 
5.3 Behavioural measures in a rat model of knee OA 
A rat model was studied for this thesis at the stages of OA where structural changes in the 
knee joint were characteristic of mild-to-moderate knee OA in humans. In chapter four, 
ipsilateral weight-bearing deficit and vertical activity limitations were identified as two 
behaviours that could potentially enhance the translatability of results from preclinical rat 
model research into clinical research settings. The knee pathology and pain 
neurophysiology domains of this rat model of post-traumatic knee OA have already been 
well characterized in other studies.14-17 The two behaviours that were identified as a part of 
this thesis could be considered to fit in the take remedial action component of illness 
perception and behaviour, based on the reasoning that these two behaviours might reflect 
strategies the rats took to avoid knee symptoms. Furthermore, these two behaviours fall 
under the psychological distress domain of phenotypes of pain in knee OA. Thus, they 
strengthen this post-traumatic knee OA model for use in preclinical research, because now 
all three domains of the phenotypes of pain in knee OA are covered by the rat model.  
 
5.4 Limitations 
There are limitations across the three studies in this thesis. Regarding chapter two, the four 
components of illness perception and behaviour are not directly part of a theoretical 
framework and have not been individually studied and validated. Such validation may 
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require expert opinion. However, experts consulted on the scoping review were satisfied 
with the formulation of the components and their definitions. Furthermore, the components 
and their definitions were informed by prior work on the conceptualization of illness 
perception, on the conceptualization of illness behaviour, on people’s lived experience with 
knee pain/OA, and were also informed by general theories and models related to how 
people respond to being ill.7, 11, 18-20   
Regarding chapter three, the results of the psychometric properties of the QuIKS-R are 
promising, but have not been verified in an independent sample. It is for this reason that a 
team of researchers and I presently engaged in ‘The QuIKS Knee Study’, which is 
presented in the future directions section that follows in this chapter. The QuIKS Knee 
Study is being conducted to provide further construct validation to, and interpretation of, 
scores on the QuIKS-R.  
Regarding chapter four, more work needs to be done to provide conclusive findings on the 
behavioural measures utility in preclinical trials using the rat model of post-traumatic knee 
OA, such as determining whether these behaviours are removed with the use of pain 
medication. Such a study would provide more evidence that would verify or refute the 
interpretation that these behavioural outcomes were related to pain in knee OA.  
 
5.5 Clinical implications 
There are several clinical implications of the findings presented in this thesis. The scoping 
review presented in chapter two provides an interpretive review of measures that may be 
useful in a multifactorial approach to assessing the phenotype of pain in people with 
symptoms of knee OA. The QuIKS-R, presented in chapter three, is a new and promising 
tool for assessment within the psychological distress domain of people with early 
symptoms of knee OA. Therefore the QuIKS-R could be crucial in identifying issues that 
clinicians could address during therapy for people with early symptoms of knee OA. 
Ideally it would be used during the initial consultation between the patient and the 
clinician. Also, the QuIKS-R could be used to identify people in the community with 
emergent chronic OA-like pain who could benefit from conservative treatment such as 
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education and exercise. The rat model study presented in chapter four was a ‘bedside-to-
bench’ work, which used knowledge from human research to inform the investigation of 
behaviours related to knee OA in a rat model of post-traumatic knee OA. Therefore, 
preclinical work performed using this model might be better translated into clinical 
settings, given that the behavioural factors in the model are now better understood.  
 
5.6 Future directions: The QuIKS Knee Study 
Currently, we are engaged in an ongoing research project called The QuIKS Knee Study. 
The project is investigating the ability of the QuIKS-R to identify people with OA-like 
knee pain who are more likely to have decreased physical activity, physical function, and 
health-related quality of life. This further validation of the QuIKS-R may prove it to be a 
useful measure for identifying, providing prognoses, and informing the therapy of people 
with knee OA-like symptoms. The QuIKS-R was created through Rasch analysis of data 
from the original 13-item QuIKS, data which were collected using a 35-item prototype 
questionnaire. Therefore, it is very important that the QuIKS-R undergo this independent 
validation with the new data being collected from its target population using this 13 item 
version.
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Appendices 
Appendix A Questionnaire to Identify Knee Symptoms (QuIKS)-R 
Questionnaire to Identify Knee Symptoms-R (QuIKS-R) 
Instructions 
Tick one box to answer each question. If you are unclear about how to answer a question, 
please give your best answer.  
Medications 
The following statements describe things you might do to manage your knee pain with 
medications. 
Tick the box that best describes how often each statement applies to you in the last 2 
weeks. 
 Never Rarely Sometimes Often Always 
1. I take pills before I do some activities to 
prevent knee pain. □0 □1 □1 □1 □2 
2. I take pills after I do some activities to 
reduce knee pain. □0 □1 □1 □1 □2 
3. I carry pills with me just in case my 
knees start to hurt. □0 □1 □1 □1 □2 
Monitoring 
The following statements describe how you may monitor your knee symptoms. 
Tick the box that best describes your agreement with each of the following statements in 
the last 2 weeks. 
 Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
4. I notice knee pain when kneeling. □0 □1 □1 □1 □2 
5. My knees feel stiff after sitting or 
standing for long periods of time. □0 □1 □1 □1 □2 
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6. My knees hurt after sitting or standing 
for long periods of time. □0 □1 □1 □1 □2 
Interpreting 
The following statements describe how you may interpret your ongoing knee symptoms. 
Tick the box that best describes your agreement with each of the following statements in 
the last 2 weeks. 
 Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
7. I talk to family and friends about 
things I can do about my knee problems. □0 □1 □1 □1 □2 
8. I consult my doctor about my knee 
problems. □0 □1 □1 □1 □2 
9. I suspect my knee problems are the 
result of getting older. □0 □1 □1 □1 □2 
10. I suspect my knee problems are 
arthritis. □0 □1 □1 □1 □2 
Modifying 
The following statements describe how you may modify activities in response to knee pain. 
Tick the box that best describes your agreement with each of the following statements in 
the last 2 weeks. 
 Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
11. I participate in certain activities less 
often to avoid aggravating my knees. □0 □1 □1 □1 □2 
12. I am considering stopping a 
favorite activity due to my knees. □0 □1 □1 □1 □2 
13. I am considering changing my 
exercise routine due to my knee 
problems. 
□0 □1 □1 □1 □2 
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The conversion table below is for Clinicians Use Only 
QuIKS-R raw total score = ____________       QuIKS-R final score = ______________ 
Conversion Table 
Total Raw Score Final Score Total Raw Score Final Score Total Raw Score Final Score 
0 100 9 66.2 18 29.7 
1 94.8 10 59.2 19 26.7 
2 90.6 11 52.9 20 23.8 
3 87.3 12 48.2 21 20.9 
4 84.4 13 44.5 22 17.9 
5 81.6 14 41.2 23 14.9 
6 78.6 15 38.3 24 11.4 
7 75.3 16 35.4 25 6.6 
8 71.2 17 32.6 26 0 
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